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ABSTRACT

THE EXPRESSION AND LOCALIZATION OF CYTOPLAMIC
POLYADENYLATION ELEMENT BINDING PROTEINS IN THE RETINA
Xiangping Wang
Nov 7,2008
The current status of our knowledge of synaptic plasticity comes largely from studies of
the hippocampus and the context of learning and memory. We remain largely ignorant of
plasticity in other neural systems and contexts. The molecular basis of plasticity has
recently been given new impetus due to the discovery of a local control mechanism
which can regulate protein synthesis at stimulated synapses. This involves the use of
cytoplasmic polyadenylation binding proteins (CPEBs) to regulate translation. The
studies presented here attempt to show that these molecular components are present in
the retina, a part of the central nervous system that has been seen, historically, as not
plastic.
Methods used: RT-PCR was used to determine the presence of mRNAs in tissue. In

situ hybridization and immunofluorescence microscopy were used for localization of
mRNAs and proteins respectively. Real-time PCR and Western blots were used for
quantifications of mRNA and proteins during postnatal development. A bioinformatics
program "CPE detector" and 3' RACE were used to identify potential mRNA targets for
CPEB1 in the UTR databases and in the retina respectively. The PAT assay was used
to determine the length of poly(A) tails for some potential mRNA targets. Data mining
and sequence alignment were used to identify alternatively spliced isoforms of CPEB3.

v

Major Results: Our results demonstrated that CPEB1-4 were all present in the retina.
The four CPEBs had similar distributions in the inner retina: predominantly in the retinal
ganglion cell layer, and to a less extent, in the inner nuclear layer. However, CPEB1 had
a laminar pattern in the inner plexiform layer, whereas CPEB3 was diffuse. The
presence of CPEB1 was minimal in the outer plexiform layer in contrast to CPEB3.
During postnatal development the levels of CPEB1, 3 and 4 were up-regulated; whereas
the level of CPEB2 was constant. Potential mRNAs were identified as targets of
CPEB1; some mRNA targets demonstrated elongated poly(A) tails at postnatal day7 or
day12, consistent with the up-regulation of CPEB1 at these ages. Multiple isoforms,
including a novel one, were identified for CPEB3. The alternative splicing of CPEB3
could occur both in the UTRs and in the coding region.
Major Conclusions/Significance: Our data demonstrated that more than one CPEB
paralog is present in mouse retina. Potential mRNA targets for CPEB1 were present in
the retina and gained elongated poly(A) tail in accordance with the up-regulation of
CPEB1 during development. The increases of CPEB1, 3 and 4 during the development
indicate a possible role of such CPEBs in synaptogenesis. Continuing up-regulation of
CPEB1, 3 and 4 also indicate a role in the adult retina. Alternative splicing in the UTRs
of CPEB3 indicates a complex regulation of CPEB3; multiple isoforms of CPEB3 protein
indicate the functional complexity of CPEB3. The presence of CPEBs in the retina
indicates the existence of a translational control system in the retina.
Future studies: Future studies should focus on the identification of mRNA targets for
each CPEB. Such potential targets can be validated using in vitro binding assays to
confirm their interaction with CPEB proteins. CPEB can be knocked-down or
overexpressed in cultured cells. CPEB knockout mice can be generated for further
functional studies.
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CHAPTER I
INTRODUCTION

1. Synaptic plasticity
The old adage "use it or lose it" has been proven correct for many generations. It vividly
defines the plasticity in a number of systems in our body, including the central nervous
system (CNS). The CNS seems to be endowed with an extraordinary degree of plasticity,
one of the important foundations for processes such as development, learning and
memory (Silva 2003; Molnar et al. 2002). It is believed that strengthening of existing
synapses and formation of new synaptic contacts underlies the formation and
consolidation of memory; while the atrophy of synapses in the absence of reinforcement
leads to forgetting (figure 1).
Synaptic plasticity is defined as "the ability of synapses to change as circumstances
require. They may alter function, such as increasing or decreasing their sensitivity; or
they may increase or decrease in actual numbers. This phenomenon is thought to be
the main source of the overall plasticity of nervous system pathways" (Dorland's
Illustrated Medical Dictionary, 29th edition). Synaptic plastiCity portrays the ability of
neurons to change their synaptic strength and efficacy of transmission in adaptation to
input. Synaptic plastiCity can be embodied in several forms, including changes in the
amount of neurotransmitters released from presynaptic terminals (Sala et al. 1998;
Rosenmund et al. 1993), alteration in the composition and number of receptors lion
channels on the postsynaptic membrane (Yashiro et al. 2005), re-remodeling of synaptic
1

Figure 1. Illustration of synaptic plasticity: memory and forgetting (LOscher et al. 2000)
This is a simple illustration for the current understanding of the formation of "memory"
with knowledge of current literature. When neurons receive high-frequency stimuli, a
series of biochemical and morphological changes occur, which ultimately lead to
strengthening of synaptic transmission and increase in the number of synapses. On the
other hand, the reverse process - ''forgetting'' can occur: the synapses undergo
"atrophy"- decrease in numbers and in its efficacy in the absence of stimuli (from right to
left).
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structure (Eliasieh et al. 2007), and an increase or decrease in the number of synapses
(Tominaga-Yoshino et al. 2008). The manifestations of synaptic plasticity can be
molecular, electrophysiological, morphological, and sometimes, behavioral. Some of the
key synaptic molecules that have long been known for their involvement in synaptic
plasticity are elaborated below:

1)

Glutamate receptors

Glutamate is the most abundant excitatory neurotransmitter in the CNS. It is released
from pre-synaptic cells following an appropriate stimulus, crosses the synaptic cleft, and
binds to its receptors on post-synaptic cell membrane.

Several types of glutamate

receptors are present on the post-synaptic cell membrane. These receptors are
categorized into two major classes: ionotropic glutamate receptors (iGluR), which are
ion channels gated by the ligand, and metabotropic glutamate receptors (mGluR), which
are coupled to secondary messenger pathways. The iGluRs are further divided into
three classes, named for the glutamate antagonist they respond to: N-methyl-Daspartate receptor (NMDAR), a-amino-3-hydroxy-5-methyl-4-isoxazole propionate
receptor (AMPAR), and kainate receptor (KAR) (figure 2). All of these types of glutamate
receptors have been implicated in certain forms of synaptic plasticity (Kullmann and
Lamsa 2008; Catania et al. 2007; MacDonald et al. 2006; Genoux and Montgomery
2007; Kim et al. 2008; Isaac et al. 2007; Lau and Zukin 2007; Shepherd and Huganir
2007; Bortolotto et al. 2005), with the best-established being NMDAR and AMPAR.

4

a) NMDAR
NMDARs are multimeric protein complexes composed of subunits named NR1, NR2 and
NR3, alternatively referred to as GRIN1-3 (figure 2a, 2b). Eight alternative splicing
isoforms of NR1 have been identified with distinct tissue distributions. Four isoforms of
NR2 (NR2A-D) are selectively expressed across various cell types, with NR2B being the
predominant isoform in neurons. The NR2 subunit possesses the binding site for
glutamate and determines the receptor's basic kinetic properties. However, the
functional properties of NMDARs arise from the differential combination of NR1, NR2
and NR3. A developmental NR2B-NR2A switch has been characterized in the CNS:
NR2B is predominant in early stages, while NR2A gradually outnumbers NR2B in the
later stages of development (Liu et al. 2004). The developmental switch from a NR2B to
a NR2A dominant form is believed to be a modulator of synaptic plasticity (MacDonald et
al. 2006) and NMDA neurotoxicity (Liu et al. 2007b; Zhou and Baudry 2006). The
integration of NR3A or NR3B to NR1/NR2 subunits modifies the ion permeability of the
receptor, and reduces NMDA-induced currents; co-assembly of NR3A or NR3B with
NR1, in the absence of NR2, forms excitatory receptors that can be activated by glycine
alone, but unaffected by glutamate or NMDA (Chatterton et al. 2002; Wada et al. 2006;
Tong et al. 2008; Awobuluyi et al. 2007). All NMDA receptor subunits are
transmembrane proteins. The intracellular domains of these subunits contain sites for
several kinases such as protein kinase A (PKA), protein kinase C (PKC),
Ca(2+)/calmodulin-dependent protein kinases (CaMKs), and tyrosine kinases that
regulate the functions of the receptors (Wang et al. 2005; Wang et al. 2006). The
intracellular domains also possess the binding sites for a series of structural, adaptor, or
scaffolding proteins (Beresewicz 2007).

5

Figure 2. Classification and nomenclature of glutamate receptors
a} Glutamate receptors are classified into two major classes: ionotropic receptors
(iGluR) which are ion channels associated with receptors, and metabotropic
receptors (mGluR) which are coupled to secondary messenger pathways. iGluR
is divided into three types depending on the agonists they respond to: NMDA
receptors (NMDAR), AMPA receptors (AMPAR), and kainate receptors (KAR).
Each ionotropic receptor is multimeric. The types of subunits are listed below for
each subtype. mGluR each is composed of one transmebrane protein subunit.
The types of subunit for mGluR are also listed.
b} Diagram of iGluR (modified from Kandel et ai, 1991). iGluRs are receptors
associated with ion channels (top). Each iGluR is composed of multiple (4-5)
subunits; each subunit is a transmembrane protein that crosses the membrane
four times (bottom).
c} Diagram of mGluR (modified from Kandel et ai, 1991). mGluRs are coupled to
secondary messenger pathways (top). Each mGluR is formed from one
polypeptide, which is a transmembrane protein that crosses the membrane
seven times (bottom).
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NMDARs (figure 3a) are Na+, K+ channels which are also highly permeable to Ca2+
(Mayer et al. 1987). NMDARs can be blocked by Mg2+ in a voltage-dependent way or by
Zn 2+ in a voltage-independent way (Westbrook and Mayer 1987). The activation of
NMDARs requires the binding of glutamate and the co-agonist glycine, as well as
membrane depolarization. Ca2+ influx via these receptors is believed to evoke
glutamate-mediated synaptic plasticity (Baba et al. 2003; Kamiya et al. 2002; Christie et
al. 1996; Cummings et al. 1996). A large amount of Ca2+ influx activates CaMKII, which
ultimately increases the number of AMPAR on the post-synaptic membrane and
elevates the efficacy of the synapses (Poncer et al. 2002). However, excessive Ca 2+
influx can also lead to too much excitation (excitotoxicity) and neurotoxicity (Meldrum
and Garthwaite 1990).

b) AMPAR
AMPARs are multimers composed of four distinct protein subunits, GluR1-4,
alternatively named as GRIA1-4 (figure 2a, 2b). Alternative splicing isoforms of each
subunit result in different functional properties such as the speed of desensitization and
resensitization. The majority of AM PARs consist of a symmetric "dimer of the dimers",
which are composed of GluR2 and either of GluR1 , GluR3, or GluR4 (Greger et al. 2007;
Mayer 2005). GluR2-containing AMPARs are well-established key players in long-term
synaptic plasticity (Isaac et al. 2007; Xia et al. 2007), although GluR2-absent AMPARs
have also been demonstrated to playa role in synaptic plasticity as well (Meng et al.
2003; Biou et al. 2008).
AM PARs are ion channels permeable to Na+ and K+ (figure 3b). Their permeability to
Ca2+ is determined by the presence or absence of GluR2. AM PARs that lack GluR2 are

8

Figure 3. Diagrams of two types of ionotropic glutamate receptors: NMDAR and AMPAR
(modified from Kandel et al. 1991)
a) NMDA receptor is selectively agonized by NMDA. The associated channels are
permeable to Na+, K+, and highly permeable to Ca2+. NMDAR has selective
binding sites for glutamate, glycine, Mg2+, Zn2+ and polyamines. The activation
of NMDAR requires the binding of both glutamate and glycine. Mg2+ and Zn2+
inhibit NMDAR in a voltage-dependent and voltage-independent way,
respectively. Polyamine is an important modulator of NMDAR.
b) AMPA receptor is selectively agonized by AMPA. The associated channels are
permeable to Na+ and K+. The permeability to Ca2+ is dependent on the
subunit composition. GluR2-lacking AM PAR is permeable to Ca2+, while GluR2containing AMPAR is almost impermeable to Ca2+. Subunit composition also
modulates the regulation of AMPAR. For example, GluR2-containing AMPAR
can be blocked by polyamine in a voltage-dependent manner.

9

Figure 3

NMOA receptor

AMPA receptor

2+ Na+

Glue
Gly

•

a

b

10

well (figure 5), including a membrane associated form of the G protein Ras (Rosen et al.
1994), Ca 2+/calmodulin activated guanine exchange factors (GEFs), and cytoplasmic
protein tyrosine kinase 2 (PTK2) (Orban et al. 1999). The activation of CaMKIl can also
contribute to the activation of ERK2 by inhibiting an ERK inhibitor synaptic Ras-GTPaseactivating protein (synGAP) (Soderling et al. 2001). A recent study demonstrated that
MAPK is required for phosphorylation of cytoplasmic polyadenylation binding protein
(CPEB1) during meiosis in Xenopus oocyte, and MAPK directly phosphorylates CPEB1
on four residues (T22, T164, 8184, 8248), but not on 8174 which is phosphorylated by
aurora kinase (Keady et al. 2007). It is not known whether MAPK can activate CPEB1 in
some form of synaptic plasticity in neurons.

4)

BDNF

Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin family and is
known to have an essential role for neuronal survival and differentiation and neurite
growth. BDNF also has an important role in memory formation and synaptic plasticity,
particularly in glutamatergic neurons. The mature BDNF form preferably binds to and
activates TrkB receptor, a member of the receptor tyrosine kinase family. Following
secondary messenger signaling cascade, activated TrkB will induce the phosphorylation
of glutamate receptor subunits thus affecting the glutamate receptor activity (figure 6)
(Carvalho et al. 2008). In contrast, the unprocessed pro-form, proBDNF is coupled to
p75 receptor and is possibly involved in cell death (Kenchappa et al. 2006). The mRNAs
of BDNF and TrkB are localized to different subcelluler locations including synapses in
the hippocampus and visual cortex. The accumulation and synaptic translocation of
BDNF mRNA and proteins was elicited by depolarization stimuli via a pathway involving
NMDAR, TrkB and an influx of Ca 2+ (Tongiorgi et al. 2006). In the dentate gyrus of rats,

21

Figure 6. BNDFrrrkB signaling pathway and synaptic plasticity (Carvalho et al. 2008)
BDNFrrrkB regulates the synaptic plasticity at glutamatergic synapses through pre- and
postsynaptic targets. Pro-BDNF is secreted from both the pre- and post-synaptic
membrane in an activity-regulated way. Mature BDNF generated by extracellular
protease digestion of pro-BDNF acts on pre- and postsynaptic TrkB receptors, which is
coupled to secondary messenger pathways. In presynaptic compartment, activated TrkB
regulates glutamate release; whereas in postsynaptic space, activated TrkB elicits
changes in glutamate receptor synthesis and phosphorylation, changes in gene
transcription and local translation. These effects of BDNFrrrkB signaling pathway result
in the modulation of synaptic efficacy and morphology.
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a brief infusion of BDNF induced the transcription and rapid dendrite trafficking of the
immediate early gene activity-regulated cytoskeleton-associated protein (Arc), which is
required for the local expansion of the actin cytoskeleton during late phase LTP (Soule
et al. 2006; Bramham and Messaoudi 2005). BDNF signaling also regulates the
localization and activation of the translational machinery, thus driving the local
translation of synaptic mRNAs such as Arc and CamKlIa (Soule et al. 2006; Yin et al.
2002; Bramham 2008; Aakalu et al. 2001).
Neurotrophin is involved in the formation of neuronal connectivity at several levels.
BDNF is involved in axonal and dentritic arborization and activity-dependent synaptic
connectivity in retinal ganglion cells (Cohen-Cory and Lorn 2004), in the hippocampus
and neocortex (Binder and Scharfman 2004).
Several independent studies demonstrated that AMPAR can induce the up-regulation of
BDNF in both Ca2 +-dependent and Ca 2+-independent manners. One study
demonstrated that activation of a tyrosine kinase Lyn by AMPAR triggers the MAPK
pathway and increases the expression of BDNF (Hayashi et al. 1999).

Two transcript variants of BDNF are produced in the brain. Although both encode for the
same protein, one has a short 3' untranslated region (3'UTR) and the other long 3' UTA.
The short 3' UTR isoform is restricted to cell somata, whereas the long 3' UTR isoform
can be located to synapses. Mutant animals with truncated long 3' UTR manifested
impaired dendritic targeting of BNDF mRNA, deficits in dendritic pruning and
enlargement, and selective impairment in long-term potentiation in the hippocampus (An
et al. 2008). The mechanism by which long 3' UTR isoform of BDNF mRNA is localized
and translated in the dendrites is yet to be determined.
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5)

Cytoskeletal, scaffolding, and adhesion molecules

Synaptic remodeling requires a dynamic synaptic architecture. Post-synaptic density
(PSD) is an electron-dense structure composed of hundreds of proteins, providing a
scaffold for the delivery of membrane-bound receptors as well as a matrix for
concentrated functional molecules such as kinases, phosphatases, and other key
molecules of various signaling pathways involved in synaptic plasticity. Prominent
members of the PSD include actin-based cytoskeleton proteins, scaffolding proteins, and
adhesion molecules (figure 7) (Boeckers 2006). Cytoskeleton molecules including actin,
spectrin, tubulin, microtubule-associated proteins have been isolated from the PSDs.
Adhesion molecules such as cadherins are also present at synaptic junctions and playa
critical role in synaptic plasticity (Huntley et al. 2002).
The structure of the PSD is dynamic. Its major component, actin, can be a stable
structural component or a dynamic filament. Drebrin, a side-binding protein of
filamentous actin (F-actin), is located in spines and regulates the recruitment of actin and
PSD-95 into filopodia, the precursor of dendritic spines (Takahashi et al. 2003; Mizui et
al. 2005; Sekino et al. 2007). The neuronal cell adhesion molecule, N-cadherin, can be
synthesized and recruited to the PSD during LTP in the hippocampus.
Insertion of NR2B-containing NMDARs to the synaptic membrane is associated with a
dynamic organization of the PSD and an actin-dependent increase in the size of
dendritic spines (Mulholland and Chandler 2007). A key cytoskeleton molecule, the
Protein Interacting with C-Kinase 1(PICK1), was recently identified as a key regulator of
AMPAR trafficking. PICK directly interacts with AM PAR and assists the removal of
AMPAR from the synaptic membrane (Hanley 2008).
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Figure 7. PSD - cytoskeletal, scaffolding, adhesion molecules and more
(http://www.mcw.edu/FileLibrary/User/mschober/PSD_diagram.jpg)
PSD forms the matrix and platform for key synaptic plasticity molecules to attach and
function. PSD is composed of hudreds of different types of proteins, namely,
cytoskeletal proteins, scaffolding proteins, adhesion molecules, and other synaptic
plasticity-associated molecules.

F-actin is one of the major components of PSD.

CaMKlla is also highly enriched in PSD. Components of CPEB complexes have also
been identified in PSD (ref). PSD provides anchor points for the enrichment of
glutamate receptors AMPAR and NMDAR; it also provides a microenviroment for
synaptic molecules such as CaMKIl and CPEBs to function.
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Figure 7
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Most of the aforementioned synaptic plasticity molecules are enriched in synapses. A
rapid regulation of their translation or synaptic localization needs to be in place in a
temporally and spatially specific manner upon the arrival of stimuli. The synthesis and
dynamic organization of these molecules is activity dependent, involving Ca 2+ influx
through activated glutamate receptors and voltage-gated calcium channels at the postsynapse (Schubert and Dotti 2007; Certner and Matus 2005). For example, activation
of NMDAR provides a regulation for the molecular conformational change of cadherin
and leads to strengthened adhesion across the synaptic cleft. Nonetheless, the
complete mechanisms of such regulation are yet to be delineated.

2. Cytoplasmic polyadenylation and translational control

Synaptic plasticity requires transcriptional and translational control for enduring changes
in synaptic efficacy (Steward and Schuman 2001; Bading 2000). It needs to be
demonstrated that the molecular processes underlying plasticity are temporally and
spatially accurate as to when and where the stimulus was received. Recent reports
indicate that local protein synthesis in dendrites under tight control may provide an
essential mechanism for long term synaptic plasticity. Cytoplasmic polyadenylation may
be able to provide a rational explanation of how this can be achieved.

It is well established that all eukaryotic pre-mRNAs undergo polyadenylation in the
nucleus before they are exported to the cytoplasm. The newly synthesized pre-mRNA is
endonucleolytically cleaved at about 10 nucleotides upstream of the polyadenylation
signal (PAS), a hexamer sequence in the 3' UTR. The poly(A) stretch is then added to
the newly formed 3' end.

The poly(A) tail and its bound proteins are important for

termination of transcription, export of the mRNA from the nucleus, and protection of the
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mRNA from degradation by exonuclease. Multiple variants of the PAS sequence have
been identified in nature with different occurrences and distinct efficiencies for
polyladenylation (table 1).

Cytoplasmic polyadenylation was first identified in eggs and two-cell embryos (Clegg
and Piko 1982; Clegg and Piko 1983a; Clegg and Piko 1983b; Wilt 1973), where little
RNA transcription activity was detected. A serine protease tissue-type plasminogen
activator (t-PA) was translated in a concerted manner in oocytes undergoing meiotic
maturation. The mRNA of t-PA accumulates during oocyte growth until the oocyte is
fully grown and arrested in meiosis. Resumption of meiosis triggered the polyadenylation
of t-PA mRNA in the cytoplasm, which was immediately followed by translation and
serves as a novel mechanism for translational regulation (Vassalli et al. 1989; Huarte et
al. 1987). Timed expression of pre-stored mRNA was also observed during early
embryonic development to initiate mitosis and in some circumstances, to dictate the
polarity of the embyo. Such translational activation was accompanied by elongation of
the poly(A) tails (Richter 1991; Simon et al. 1992). The same mechanism was later
discovered to be employed by the hippocampus and several other parts of the central
nervous system, for the acquisition and consolidation of memory, or for long-term
synaptic plasticity.

Both a PAS motif and a U-rich motif are required for cytoplasmic polyadenylation of
mRNAs' (Fox et al. 1989; McGrew et al. 1989). This short U-rich sequence UUUUUAU
was later dubbed the "cytoplasmic polyadenylation element" (CPE) (Fox et al. 1989).
Several variants of CPE sequence have been identified (McGrew and Richter 1990;
Simon et al. 1992) (table 2). CPE is often located upstream of the PAS within a distance
of -10 nt to 100 nt, but in some instances overlaps with the PAS (figure 8).

Many

mRNAs have more than one CPE in their 3' UTA. The variant, the number of copies of
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Table 1. Variants of polyadenylation signal (PAS) and their occurrence
Data were adapted from (8eaudoing et al. 2000). "% sites" represented the
occurrence of the hexamer within 50 nt upstream of potential poly(A) sites. A
total number of 5647 putative poly(A) sites (generated by comparing human
UTRs to EST sequences) were studied.

Sequence

% sites

AAUAAA

58.2

AUUAAA

14.9

AGUAAA

2.7

UAUAAA

3.2

CAUAAA

1.3

GAUAAA

1.3

AAUAUA

1.7

AAUACA

1.2

AAUAGA

0.7

AAAAAG

0.8

ACUAAA

0.6
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Table 2. Variants of CPE sequence
Sequences of CPE variants appeared in the literature are listed below (Fox et al. 1989;
McGrew and Richter 1990; Simon et al. 1992).

Sequence

UUUUAUU
UUUUUAU
UUUUAAU
UUUUGUU
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Figure 8. Features of mRNA targets for cytoplasmic polyadenylation
The mRNA targets for cytoplasmic polyadenylation have two specific motifs in their 3'
UTRs: cytoplasmic polyadenylation element (ePE) and polyadenylation signal (PAS).
CPE is often located upstream of PAS, with a gap usually less than 100 nt. In some
instances, ePE overlaps with PAS. Some mRNA targets have more than one ePE or
PAS motifs in their 3' UTRs. The consensus sequences for ePE and PAS are listed.
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CPE and the distance to the PAS are widely variable for different mRNAs. Such
variables could indicate the presence of modulators of the process of translational
control.

The CPE binding protein (CPEB) was first identified in 1990 in Xenopus oocytes
(McGrew and Richter 1990; Paris et al. 1991). The term CPEB became interchangeable
with CPEB1 later as more paralogs were identified. Invertebrate CPEB homologs have
been documented for Drosophila (Chang et al. 1999), zebrafish (Bally-Cuif et al. 1998),
C. e/egans (Luitjens et al. 2000), clam (Walker et al. 1999) and Aplysia (Si et al. 2003a).
Studies on the mechanisms of CPEB-regulated translational control have been
extensively focused on CPEB1. Although evidence suggested that similar machineries
are employed in oocytes, early embryos, and CNS, the major discoveries were derived
from work in oocytes, since oocyte maturation is a more facile and efficient model for
CPEB1-regulated translational control. The complete mechanisms of CPEB1 regulated
polyadenylation/translation is yet to be fully delineated.

The current state of our

knowledge is summarized below.

1) CPEB 1-mediated translational control and its mechanisms

Translation of maternal mRNAs is triggered by progesterone stimulation during oocyte
maturation.

Activation of progesterone receptors induces a cascade leading to the

phosphorylation and activation of CPEB1, which is closely associated with the plasma
membrane. One of the first mRNAs that undergo polyadenylation and translation is mos,
which codes for a serine/threonine kinase.

Mos protein

polyadenylation-induced translation of cyclin B1 mRNA.
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in turn assists the

Cyclin B1 together with its

bound cyclin-dependent kinase 1 (cdk1) will then be responsible for a series of events
leading to oocyte maturation (Richter 2007).

CPEB1 has a dual role: a translational activator and a translational inhibitor (figure 9).
Under quiescent conditions, unphosphorylated CPEB1 binds to the 3' UTR of mRNA and
represses translation.

When cells respond to appropriate stimuli, the activation of

CPEB1 via phosphorylation or the degradation of CPEB1 removes the repression and
allows translation to initiate. The complete mechanism through which CPEB1 regulates
polyadenylation is yet to be completely elucidated, but current knowledge indicates that
it involves both the 3' and 5' end of the mRNAs. In the dormant state, an adaptor protein,
maskin, interacts with both CPEB1 (which binds to CPE in the 3' UTR of the mRNA) and
eukaryotic translation initiation factor 4E (eIF4E, which binds to 5' cap of the mRNA)
(Stebbins-Boaz et al. 1999). This binding bends the mRNA molecule to bring its 3' and
5' ends close together.

The interaction of maskin to elF4E excludes eukaryotic

translation initiation factor 4G (eIF4G) from binding to e1F4E. This blocks the assembly
of the complete translational machinery. Phosphorylated CPEB is transformed into an
activator which gains enhanced affinity for Cleavage and Polyadenylation Specific Factor
(CPSF), which in turn recruits Poly(A) Polymerase (PAP) and initiates polyadenylation.
The newly synthesized poly(A) tail is quickly bound and protected by Poly(A) Binding
Protein (PABP) , which subsequently recruits translational initiation factor elF4G to
displace maskin from elF4E (figure 9). This stabilized eIF4E-4G interaction enrolls the
ribosome for initiation of translation.

This model is supported by multiple studies on oocyte maturation. Maskin, CPSF, PAP
and other components have been isolated from the cytoplasmic polyadenylation
complex (Mendez et al. 2000; Barnard et al. 2004).
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Figure 9. Diagrams of the mechanism for CPEB1-regulated translational control during
oocyte maturation (modified from Groisman et al. 2002)
a) Under dormant state, CPE-containing mRNAs are bound by unphosphorylated
CPEB1, which also binds to maskin, an adaptor protein. Maskin in turn binds to
eIF-4E and prevents the association of eIF-4E with eIF-4G. In this configuration,
mRNA translation is repressed. The cleavage and polyadenylation specific factor
(CPSF) mayor may not be associated with PAS prior to activation.
b) When CPEB1 is phosphorylated in response to progesterone stimulus, it
acquires increased affinity to CPSF. CPSF then binds to PAS and recruits
polyadenylation polymerase (PAP), which results in the elongation of the poly(A)
tail. Newly synthesized poly(A) tail is bound and protected by poly(A) binding
proteins (PABP), which facilitates the recruitment of eIF-4G. eIF-4G displaces
maskin from eIF-4E. The association of eIF-4E and eIF-4G recruits the ribosome
for the initiation of translation.
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Figure 9

a
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2) Characterization of CPEB2, CPEB3, and CPEB4
Besides the intensively-studied CPEB1, three additional paralogs of CPEB have been
identified in rodents. Mouse CPEB2 was identified as abundant in post-meiotic haploid
cells in testes and may have a role in spermatogenesis. Reverse transcriptionpolymerase chain reaction (RT-PCR) demonstrated that CPEB2 was also expressed in
cerebrum, cerebellum, salivary gland, thymus, liver, spleen, kidney, intestine, testis, and
ovary (Kurihara et al. 2003). A systematic screen with PCR for CPEB genes in mouse
brain revealed another two novel paralogs: CPEB3 and CPEB4.
Sequence alignment demonstrated a less homologous N-terminus and a highly
conserved C-terminus, among different paralogs and across species (figure 1Oa). Two
RNA recognition motifs (RRF) and a zinc finger region in the C terminal region are
indispensible for RNA binding, as demonstrated by deletion experiments, and are highly
conserved (Theis et al. 2003). Interestingly, rodent CPEB2, 3, and 4 share a much
higher homology to one another than to CPEB1 (figure 10b). Cross-species
comparisons demonstrated that mouse CPEB 1 is closer to Drosophila CPEB than to
mouse CPEB2, and mouse CPEB2 is closer to Drosophila CPEB2 than to mouse
CPEB1 (Theis et al. 2003). Such evidence strongly indicates that CPEB2, 3, and 4
belong to a different subfamily which is rather distant from CPEB1.
Multiple alternatively spliced isoforms have been identified for each of CPEB2, 3 and 4
(Theis et al. 2003). The identified variable regions are the so-called B-region and Cregion (figure 11 a, 11 b). The significance of the C-region is unknown, but the B-region
harbors the recognition sites for PKA, CaMKII, and p70S6 kinases (figure 11c). Unlike
CPEB1, CPEB2-4 have no phosphorylation site for aurora kinase. But isoforms of
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Figure 10. Comparison of mouse CPEB1-4
a) The general structure of the CPEB proteins. The N terminus region is highly
variable for different CPEBs, while the C-terminus is highly conserved. Two RNA
binding motifs (RRM) together with a Zinc finger domain appear to be
indispensable for RNA binding.
b) Homology score of the full-length proteins and of the RNA-recognition motifs
(RRM) between CPEB1-4 (Theis et al. 2003). In the overall structure, CPEB2-3,
CPEB2-4, and CPEB3-4 demonstrate much higher identity (69.9,67.7, and
56.8% respectively) than with CPEB1. Similarly, in the RNA recognition motifs,
CPEB2-4 are almost identical (97-99%), whereas CPEB1 shares only 44.9%
sequence with the other three. Comparisons were calculated using ClustalW.
Scores represent the percentage of identical sequences.
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Figure 11. Known alternatively spliced isoforms of CPEB2-4 (modified from Theis et al.
2003)
a) Schematic view of known mouse CPEB3 splice isoforms. (upper) CPEB3
contains two amino acid stretches that are absent in some variants. The B
region (hatched box) contains putative phosphorylation sites (filled circle) for
PKC, CaMKlla and p70S6 kinases. The C region is upstream of the B region.
The C and B regions can be spliced out individually or concurrently.
b) Schematic view of known mouse CPEB4 spliced isoforms. For explanations, see
a). Unlike CPEB3, the B region is not separated from C region in CPEB4.
c) Sequence comparsion of variable regions Band C in mouse CPEB2, 3, and 4
proteins. The B region is present in some variants of all three CPEBs. Putative
phosphorylation sites for PKA, CaMKIl and p70S6 kinases are shown above the
sequences, and the phosphorylaton site is indicated with an asterisk. The
corresponding actual recognition sites are shaded. Note that the phosphorylated
serine residue is not in the variable region, but the deletion of B region would
disrupt the recognition site.
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CPEB2-4 containing the B-region can be phosphorylated by PKA, CaMKIl and p70S6
kinase (Theis et al. 2003).
Different expression patterns have been characterized for CPEB1-4 in the brain. In the
hippocampus, CPEB1, 2 and 4 mRNAs are all present in the CA1/CA31ayers and
dentate gyrus. CPEB3 is barely detectable in these layers in the naIve state, but
together with CPEB4 it is strongly up-regulated in kainaite-induced seizure. Notably, the
CPEB3-4 isforms that were up-regulated after kainaite treatment were the ones
containing the B-region (Theis et al. 2003) which possesses the phosphorylation site for
PKA, CaMKIl and p70S6 kinases. Both CPEB3 and CPEB4 were strongly detected in
post-synaptic density factions (Huang et al. 2006). In the cerebellum, both CPEB3 and
CPEB4 were demonstrated in the granule cells. However, only CPEB3 appeared in the
interneurons, and only CPEB4 appeared in the Pukinje cells. Additionally, CPEB3, but
not CPEB4, appeared in the mitral cells of the olfactory bulb (Huang et al. 2006).

Very little is known of the mechanisms by which CPEB2-4 operate. Based on the
wide disparity in CPEB1 and CPEB2-4 sequences and differences in their tissue
distribution, it is plausible that CPEB2-4 utilize distinct mechanisms from CPEB1.
CPEB2-4 may be activated by different kinases such as PKA, CaMKlla, and p70S6
while CPEB1 can be phosphorylated by aurora kinase.
different substrate specificities.

CPEB2-4 may have

Huang and colleagues (Huang et al. 2006)

demonstrated that CPEB3 recognizes a U-rich hairpin secondary structure in the 3'
UTR of mRNAs (figure 12). The binding of CPEB3 to the hairpin motif and the
binding of CPEB1 to the CPE motif is exclusive. CPEB3 but not CPEB1 protein
binds to GluR2 mRNA both in vitro and in vivo. The application of CPEB3 siRNA in
neurons resulted in an elevated level of GluR2 proteins (Huang et al. 2006). Similar
to CPEB1, CPEB3 seemed to be a translational inhibitor of a reporter gene
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Figure 12. RNA secondary structure for CPEB2-4 binding (Huang et al. 2006)
a) A library of artificial RNA was generated from in vitro transcription. The
oligonucleotide library composed of random 25-mers (variable sequence) flanked
by constant sequences. The mixture was tested for binding to RBO of CPEB4
using systematic evolution of ligands by exponential enrichment (SELEX) method.
RNAs that had high binding affinity to the RBO of CPEB4 were listed.
b) Predicted RNA secondary structure necessary for CPEB4 binding. A U-rich loop
and a proximal stem upstream were both required. The nucleotides in the boxes
indicated the ones protected by CPEB4. This model could be generalized to
CPEB2-4, since the RBOs of these are almost identical.
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construct in a naive stage, and transforms into an activator upon NMDAR
stimulation. CPEB3-mediated translational control appeared to be independent of
polyadenylation since it did not bind to CPSF nor did it require the PAS signal
(Huang et al. 2006).

3. CPEBs and synaptic plasticity

Neurons are highly polarized cells that require differential distribution of proteins
and mRNAs to different cellular compartments such as somata, axon and dendrites.
A neuron can receive signals from thousands of cells. A dendrite that receives a
signal is distinguished from many other dendrites that do not by establishing a "tag"
of the stimulated synapse. This "tag" is composed of up-regulated proteins which
will affect the way the synapse responds to stimuli in the future. Formation of such
synaptic plasticity requires both temporally and spatially regulated translation at the
synaptic sites. Many components of the protein synthesis machinery, including
polysomes, CPEBs, and mRNAs are present in dendrites.

This indicates that

CPEB-mediated local translational control in response to synaptic activation could
be one of the underlying mechanisms of synaptic plasticity (figure 13).

1) CPEB1 and synaptic plasticity
Intriguingly, the translational mechanisms employed by CPEB1 in oogenesis and early
embryogenesis could be recapitulated in the brain. The CPEB that was most intensively
studied for its role in synaptic plasticity is CPEB1. Localized translation at the synaptic
sites is one of the essential underlying mechanisms for neuronal processes such as
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Figure 13. Cytoplasmic polyadenylation and translation in neurons (Wells et al. 2000)
Synaptic plasticity induces protein synthesis in neurons. CPEB is localized to synapses
and enriched in the postsynaptic density (PSD) in the brain. Activation of NMDAR
triggers the phosphorylation of CPEB and initiation of its target mRNAs (ref). This model
is supported by the discovery that CPE-containing mRNA, CaMKlla, is enriched in PSD.
Its polyadenylation and translation was up-regulated in the visual cortex of dark-reared
animals when these animals were exposed to light (Wu et al. 1998). This process was
blocked by antagonist of NMDAR or inhibitors of polyadenylation (Kirkwood et al. 1996;
Wells et al. 1999). The mechanism of how NMDAR activates CPEB is yet to be
determined (as indicated by"?").
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long-term memory and long-term synaptic plasticity. However, the mechanism by which
translation is controlled and by which the proteins encoded modulate the prolonged
changes biochemically is largely unknown. Some factors, including RNA-binding
proteins and their target mRNAs at synaptic sites have been identified. For example,
CPEB1 and Fragile-X Mental Retardation Proteins (FMRP) both have a function in the
localization and translation of synaptic mRNAs. Because of the difficulty to manipulate
primary neuron cultures such as low transfection rate for non-dividing cells, biochemical
approaches to study the mechanisms are often carried out in more facile and efficient
systems such as the oocyte. However, several techniques including the development of
knockout animals, various viral delivery systems, small interference RNA (siRNA)
knockdown techniques, have enabled some analysis of translational mechanisms in
neurons. A surrogate system has also been employed by injecting brain-derived
mRNAs into Xenopus oocytes to test their polyadenylation by CPEB1.
CPEB1 is localized to dendritic layers of the hippocampus, the synapses in cultured
neurons, and PSDs in adult brain. CPEB1 was phosphorylated upon NMDAR receptor
activation, and triggered the polyadenylation and translation of CaMKlla mRNA at the
synaptic sites (Huang et al. 2002; Wu et al. 1998). In CPEB1 knockout mice, several
forms of electrophysiological features of Schaffer CA 1 neurons in response to single
100-Hz stimulation and single theta burst stimulation were impaired, suggesting CPEB1
plays a role in synaptic plasticity (Alarcon et al. 2004). Administration of CPEB siRNAs to
the Aplysia neurons resulted in failure of the maintenance of long-term facilitation (Si et
al. 2003a).
Very few mRNAs are known CPEB1 targets in neurons. CaMKlla (Wu et al. 1998) and
tPA (Shin et al. 2004) are two known mRNAs that undergo activity-dependent
polyadenylation in hippocampal neurons. However, neither of these mRNAs appeared
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to be responsible for the deficiency in plasticity observed in CPEB1 knockout mice (Silva
et al. 1992b; Frey et al. 1996). This suggested the presence of other mRNAs in neurons
whose translation is regulated by CPEB1. A recent study screening mouse brain
mRNAs using the surrogate system identified six mRNAs (all have potential involvement
in synaptic plasticity): AMPA receptor binding protein (ABP), a potassium channel ELK2,
CaMKII~,

microtubule-associated protein 2 (MAP2), and rat calmodulin (RCM3) mRNAs

which became polyadenylated in response to synaptic activity (Ou and Richter 2005).
The same study demonstrated that in synaptosomes treated with glutamate, the proteins
levels of MAP2 and ABP increased significantly by 35% and 72%, respectively,
compared to untreated control.
CPEB 1 can be activated via several pathways. The induction of CPEB 1 phosphorylation
and polyadenylation in the hippocampus can be elicited by NMOA, but not AMPA
(Huang et al. 2002). Kainate has been demonstrated to trigger CaMKlla up-regUlation in
the CA3 region of the hippocampus, an event that was blocked by a protein synthesis
inhibitor cyclohexamide (Lee et al. 2003); kainate was also shown to stimulate
polyadenylation (Ou and Richter 2005). It is likely that kainate-induced translation of
CaMKlla occurred through CPEB1-mediated polyadenylation, which would indicate that
CPEB 1 can be activated via kainate glutamate receptors. Another study observed that
metabotropic glutamate activation triggered the polyadenylation of tPA mRNAs,
suggesting that CPEB1 may be activated through metabotropic glutamate receptors
(Shin et al. 2004).

2) CPEB2-4 and synaptic plasticity
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Although all four CPEBs have been identified in the nervous system, and the expression
pattern has been characterized in some regions of the brain including the hippocampus,
very little is known about the functions of CPEB2-4 in synaptic plasticity. CPEB3 is the
second CPEB that has been under investigation in recent years. The mRNA of a key
synaptic plasticity molecule, GluR2, can be bound by CPEB3. CPEB3 siRNA delivered
to neurons led to elevated levels of GluR2 protein (Huang et al. 2006).
Although some aspects of the involvement of CPEB1 in synaptic plasticity have been
revealed, such as the regulation of CaMKlIa translation, little is known about the roles of
CPEB2-4 in synaptic plasticity. Sequence alignment demonstrated a close proximity of
CPEB2-4 in the family tree but a wide distance to CPEB1. CPEB2-4Iack the
phosphorylation site for aurora kinase, a known activator for CPEB1 (Theis et al. 2003).
But some alternatively spliced isoforms of CPEB2-4 have the B-region which is absent in
CPEB1. The B-region possesses phosphorylation sites for PKA, CaMKlla, and p70S6
kinases (Theis et al. 2003). These data indicated that CPEB2-4 may be activated via
distinct pathways than CPEB1. In kainate-induced seizures in the hippocampus, the
expression of CPEB3 and CPEB4, but not CPEB1, were dramatically increased (Huang
et al. 2006), suggesting that CPEB3 and 4 are responsible for different forms of plasticity
compared to CPEB1. A U-rich loop secondary structure in the 3' UTR of mRNAs, but
not CPE, is required for CPEB2-4 binding (Huang et al. 2006), indicating CPEB2-4 have
discrete set of mRNA targets distinct from CPEB1. However, functional compensation
or redundancy between CPEB1 and CPEB2-4 is not ruled out, since LTP was not
completely eradicated in CPEB1 knockout mice. What is noteworthy is that CPEB3 may
form a positive or negative feedback loop for CPEB1, since its mRNA contains two CPE
sites in the 3' UTA.
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4. ePEB and RNA localization

ePEB regulated translation of ePE-containing mRNAs is a temporally or spatially tightly
controlled

process.

It is the common

underlying foundation

for oogenesis,

embryogenesis and would be a requirement for the demonstration of specificity of
synaptic plasticity. Both ePEB protein and its target mRNAs need to be localized to the
proper location for the local control of translation. The cis-element ePE in the 3' UTR of
mRNA molecules and the RNA-binding protein ePEB have been demonstrated in the
transport of such mRNAs.

1) ePEB and mRNA localization in Drosophila

Localized maternal mRNA is essential for the establishment of polarity in early
development.

The Drosophila CPEB homolog, orb, is required at multiple steps of

oogenesis and is important for the establishment of both dorsal-ventral (OV) and
anterior-posterior (AP) poles in early embryo development. Several maternal mRNAs are
known to be involved in the establishment of these polarities, such as bicoid (St
Johnston and Nusslein-Volhard 1992), nanos, oskar (Ephrussi et al 1991), fs(1 )K1 0 and
gurken (Haenlin et al. 1987, Cheung et al. 1992; Neuman-Silberberg and Schupbach
1993). Under normal development these mRNAs are localized to a specific pole and are
translated upon fertilization to generate gradient proteins which then direct the
localization or expression of other genes to generate the polarity of the developing
embryo. Localization of such mRNAs to specific locations requires both cis-elements
and trans-elements. The cis-elements are specific "tags" in the mRNA sequence that
mark the mRNA for localization. They are specific motifs to be recognized and bound by
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RNA binding proteins. The trans-elements are RNA-binding proteins that transport and
anchor the mRNA molecules to proper locations. Such trans-elements include general
cytoskeleton proteins such as microtubules (Pokrywka and Stephenson 1991; Theurkauf
et. al 1992) and staufen protein (Ferrandon et al. 1994; Micklem et al. 2000).

The

Drosophila CPEB homolog, orb, is involved in mRNA localization (Lantz 1992), with a

complex localization pattern evident during oogenesis (Bally-Cuif et al. 1998). Several
orb site mutations in Drosophila oocytes caused stalled development in the 8-cell cyst or
16-cell cyst stage. A less severe mutation did not stop the development but did cause
abnormal distribution of mRNAs along both AP and DV poles. Maternal mRNAs such as
oska, gurken and 1s(1 )K1 0 are misplaced in the orb mutant (Christerson and Mckearin
1994; Lantz et al. 1994).

2) CPEB and the mRNA transportation in Xenopus oocytes

During Xenopus oocyte maturation, mRNAs coding for c-mos, cdk2, several cyclins
among others, undergo cytoplasmic polyadenylation and translational up-regulation.
Several mRNAs are regionally concentrated in Xenopus oocyte (Schnapp et aI., 1997).

CPEB proteins and maskin are moderately concentrated in the animal pole in Xenopus
oocytes, and became more concentrated in eggs and early embryos due to the dominant
protein degradation in the vegetal pole. Both proteins colocalized with a-tubulin on the
centrosomes and mitotic spindles in the animal pole. Two mRNAs, xub3 and cYciin B1,
both containing CPE motifs in the 3' UTR, are localized with or near CPEB on
centrosomes or spindles (Groinsman et al. 2000). While the importance of xbub3 is not
known, cyclin B1 is important for cell cycle. Injection of CPEB antibody, mutant CPEB
with disrupted phosphorylation site, or a polyadenylation inhibitor cordycepin (3'-dATP),
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blocked cytoplasmic polyadenylation-induced translation of cyclin B1 (Groinsman et al.
2000). A CPEB mutation that does not bind to the centromere in vivo disrupted the
localization of cyclin B1 mRNA.

Such findings indicated a role of CPEB for the

localization of CPE-containing mRNAs, consistent with the observation in Drosophila
and zebrafish.

3) CPEB and mRNA localization in the CNS

In neurons, local translational regulation of synaptically enriched mRNAs such as the
activity-dependent cytoskeleton protein Arc (Steward et al. 1998), MAP2, CaMKlla
(Roberts et al. 1998), BDNF, and TrkB (Tongiorgi et al. 1996) is implicated in synaptic
plasticity. The mechanism for the localization of such mRNAs to synapses is yet to be
delineated. Recent evidence indicates that the cis-element CPE is sufficient to direct
CPE-containing mRNAs to the dendrites, and the process of such localization is
facilitated by CPEB.

CPEB, together with its adaptor protein maskin, forms RNA-

containing particles that were transported to dendrites in a microtubule-dependent
manner, suggesting that these mRNAs were transported in a translationally dormant
form. Such transportation particles also contained the molecular motor dynein and
kinesin. The transport of dendritically localized mRNAs was enhanced in neurons
overexpressing CPEB, but inhibited in neurons expressing mutated CPEB or in CPEB
knockout mice (Huang et al. 2003).

5. Synaptic plasticity in the neural retina
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The neural retina is located at the back of the eye (figure 14). It receives light stimulus
and sends the signal to the upper levels of the visual system. The retinal circuitry is
composed of primarily vertical pathways with inhibitory modulations from lateral
pathways (figure 15): Light projects on the light-sensitive photoreceptor cells in the outer
nuclear layer (ONL), which will transmit signal to the interneurons- bipolar cells in the
inner nuclear layer (INL), which will then relay signal to the ganglion cells in the retinal
ganglion cell layer (RGC). Retinal ganglion cells ultimately collect the signal and project
it to higher center of the visual system. The excitatory neurotransmitter glutamate is the
predominant neurotransmitter employed in the vertical pathway.
In addition to the vertical pathway, there are two tiers of lateral pathways: Horizontal
cells in the outer boundary of the INL integrate signals from multiple photoreceptor cells
and modulate them as necessary before sending them on to bipolar cells. Amacrine
cells in the inner boundary of the INL integrate and modulate signals from bipolar cells
before sending them on to the retinal ganglion cells. The predominant neurotransmitter
used in the lateral pathways is gamma-aminobutyric acid (GABA).
Synaptic connections of the retina are located within well-characterized laminar
structures: the outer plexiform layer (OPL) and the inner plexiform layer (IPL). The OPL
is composed of synaptic connections between photo receptors, bipolar cells and
horizontal cells. The IPL is composed of synaptic connections between bipolar cells,
ganglion cells and amacrine cells.
SynaptiC plasticity has long been recognized at higher levels of CNS, such as the
cerebral cortex (Cheetham et al. 2008), the hippocampus (Nicoll and Schmitz 2005), and
the cerebellum (Jorntell and Hansel 2006). It has also been depicted at higher levels of
the visual system (Karmarkar and Dan 2006). Neuroscientists have long thought that
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Figure 14. Diagram of the eye (www.nei.nih.gov/health/eyediagram/eyeimages2.asp)
The diagram shows the location of the retina within the eye. The retina is the innermost
layer at the back of the eye. Light enters the cornea, passes through the lens and is
projected onto the retina, where it is converted into electrochemical signals and sent
through the optic nerve to higher centers in the brain for further process of visual
perception.
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Figure 15. Diagram of the retina (Kandel et al. 2000)
This figure illustrates the laminar structure, the major cell types, and the vertical and
horizontal pathways of the retina. The retina has a unique laminar structure. From the
outer part of the eye to inner part of the eye, lie outer nuclear layer, outer plexiform layer,
inner nuclear layer, inner plexiform layer, and ganglion cell layer. Light stimulus enters
the eye and projects on photoreceptors (rods or cones). Photoreceptors then send
signals via vertical pathway to bipolar cells, and to ganglion cells. The vertical pathway
is modulated by horizontal pathway from horizontal cells at the outer plexiform layer and
from amacrine cells in the inner plexiform layer. The ganglion cells send output to higher
levels of the visual system through the optic nerve.
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layer

the neural retina lacks the property of plasticity. However, recent studies have provided
several lines of evidence, including morphological, molecular and electrophysiological
observations, which support the notion that synaptic plasticity is present in the retina.
For example, synaptic remodeling in the outer plexiform layer has been observed as a
result of photoreceptor loss in transgenic, diseased, or ageing retina. An increase in the
number of synaptic ribbons per synapse, together with an increase in the number of
processes originated from bipolar neurons participating in these synapses, were
observed in mice with degenerated photoreceptors (Jansen et al. 1997). Ecotopic
synaptogenesis - rod bipolar cell terminals extended into the outer nuclear layer to
reconnect with degenerated rod terminals- has been observed in rod-specific mutation
models (Peng et al. 2000; Peng et al. 2003), in retina of epilepsy patients treated with a
GABA-transaminase inhibitor vigabatrin (Wang et al. 2008), in retinal of AMD patients
(Sullivan et al. 2007), and in normal ageing retina (Eliasieh et al. 2007).

Dark-rearing suppressed the maturational pruning in the inner plexiform layer, of
bistratified dentrites into the characteristic monostratified pattern which normally occurs
after eye-opening (Tian and Copenhagen 2001; Tian and Copenhagen 2003). In addition,
visual deprivation elevated the expression of several important synaptic components,
such as CaMKII, GluR1 and NR1 in the retinal ganglion cells (Xue et al. 2001; Xue and
Cooper 2001). Light responsiveness measured as electroretinogram (ERG) and
oscillatory potentials (OP) were inhibited in both young and adult dark-reared animals
(Vistamehr and Tian 2004). Even under normal diurnal environment, AMPARs undergo
rapid recycling via endocytosis and exocytosis in the retinal ganglion neurons (Xia et al.
2006), and such rapid cycling is primarily restricted to GluR2-containing AMPARs (Xia et
al. 2007), which playa pivotal role in long-term synaptic plasticity (Tanaka et al. 2000;
Isaac et al. 2007). Together, these data support the notion that plasticity is a
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phenomenon that is a characteristic of retinal synapses as it is for synapses in other
parts of the CNS.

Synaptogenesis is a postnatally ongoing process in the rodent retina. Rodent retina is
premature and the synaptic structure is not well-established at the time of birth. It is not
until approximately eye-opening stage, which is about 14 days postnatally in mouse that
the synaptic structure in the plexiform layers becomes functional (Tian and Copenhagen
2001). Synaptogenesis in the inner plexiform layer (IPL) starts at day 3 and continues
until before eye-opening, when the rate of synaptogenesis in the INL drops precipitously
(Fisher 1979b; Fisher 1979a). Robust glutamatergic synaptic formation occurs in the
second postanatal week, and synaptic sublamina becomes visible in the inner plexiform
layer on postnatal day 12 (P12) (Sherry et al. 2003). Synaptic connections in OPL begin
to develop on postnatal day 3 (P3) and are well established by P12, when the first light
response was recorded as ERG (Rich et al. 1997). A diagram illustrating the
morphological maturation of synaptic structures between different types of cells is
presented in figure 16.

6. CPEBs and CPE-containing mRNAs in the retina
Several findings have indicated the presence of cytoplasmic polyadenylation in the retina.
Of the four mouse CPEBs (CPEB 1-4) characterized to date (Gebauer and Richter 1996;
Theis et al. 2003; Kurihara et al. 2003), one (CPEB1) has been shown to be present in
the mouse retina of both wildtype and rod-ablated model (rdta) mice (Liu et al. 2000).
Multiple studies have shown that the mRNA of a key molecule for synaptic plasticity,
CaMKlla, which has two CPE motifs in its 3' UTR, is present in the retina (Liu and
Cooper 1996; Cooper et al. 1995; Terashima et al. 1994), and could possibly be involved
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Figure 16. Timeframe of synaptogenesis in mouse retina (modified from Olney 1968)
Time table of morphological maturation for the synapses in mouse retina. Heavy lines
indicated periods of accelerated development; broken lines indicated periods of relative
quiescence or slow development. R-photoreceptors; H-horizontal cells; BP-bipolar cells;
A-amacrine cell; G-ganglion cell.
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in the dendritic development and/or plasticity (Okada et al. 1999; Weiler et al. 1996;
Weiler et al. 1995). The early growth response factor-1 (EGR1), a member of zinc-finger
transcription factor family, is expressed in synapses across the retina. The longer form
of its two alternative spliced mRNA isoforms possesses a CPE in its 3' UTR, and
therefore can translate rapidly upon excitatory stimuli such as light and NMDAR
activation (Simon et al. 2004). A key synaptic plasticity molecule GluR2 contributes to
the physiological property of AMPARs and is present in neurons in the retina (Hughes et
al. 1992; Hamassaki-Britto et al. 1993). It is unknown whether the other CPEBs are also
expressed in the retina and this lack of knowledge will hamper further characterization of
any putative retinal synaptic plasticity.
In this study, the presence, the localization and the expression patterns of all four
CPEBs in the mouse retina were investigated. The developmental appearance of all
four CPEBs during postnatal development was characterized. Potential mRNA targets
for CPEB1, whose cis-acting element is well established, were studied. The alternative
spliced isoforms of CPEB3 associated with the retina was explored.
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CHAPTER II
HYPOTHESIS AND SPECIFIC AIMS

The retina is a favorite model for the study of the central nervous systems because it is
an accessible part of the brain (Dowling 1987) with an endowed fine laminar structure
and easy access for molecular and electrophysiological manipulations. The well-defined
cellular types and neuronal pathways between distinct cell types could make the retina
an invaluable tool for neurobiological studies.
Synaptic plasticity has long been appreciated at higher levels of the visual system. The
neural retina as part of the central nervous system contains the same kind of synaptic
machinery as other regions of the brain (Dowling 1987). This prompted the questions
regarding the presence of synaptic plasticity in the retina. Several lines of evidence
demonstrated that the retina is capable of remodeling its synaptic structures. The
synaptic structures of the IPL of mouse retina are disoriented at birth, but become wellestablished multiple sublaminae before eye-opening. Such a process was retarded in
animals subjected to dark-rearing (Tian and Copenhagen 2001). The fine structures of
the OPL synaptic connections have also been demonstrated to undergo profound
remodeling under certain conditions. Morphological alterations have been observed in
rod bipolar cell terminals in ageing or diseased models. Light responsiveness measured
as ERGs and OPs were inhibited in both young and adult dark-reared animals
(Vistamehr and Tian 2004). The NMDAR-associated currents were down-regulated in
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concurrence with eye-opening in na'ive animal, but such an alteration was impeded in
dark-reared animals. These manifestations in morphology and electrophysiology
indicated that the retina has some degree of plasticity.
Some key molecules involved in activity-dependent synaptic plasticity have been
identified in the retina. Cytoplasmic polyadenylation, the underlying mechanism for
activity-dependent long-term plasticity in the hippocampus and the visual cortex, has
been indicated to be present in the retina. A previous study observed CPEB1 in the
retina of both wildtype mice and rdta mice (Liu et al. 2000). Other molecules implicated
in synaptic plasticity such as CaMKlla and GluR2 mRNA, which can be recognized by
CPEB1 and CPEB3 respectively, are enriched in the synapses of the retina. EGR1, an
early gene that encode for a transcriptional factor in long-term synaptic plasticity, is
present in the retina with two alternative splicing isoforms. The translation of the longer
version of EGR1 transcript which has CPE in its 3' UTR is regulated by excitatory stimuli
such as light and NMDAR activation in the retina (Simon et al. 2004). If the elements
which endow synapses with the property of plasticity can be found in the retina, it would
enhance its reputation as a more accessible model for such studies.
Based on the observations of previous studies, I hypothesize that more than one paralog
of CPEB is present in the retina.

Aim1: To determine the expression pattern of CPEB1 in the retina.
Specifically, this aim will investigate the types of cells expressing CPEB1; the regulation
of CPEB1 during the development, and the potential mRNA targets of CPEB1 in the
retina. The localization of CPEB1 will be explored with in situ hybridization at the mRNA
level and immunofluorescence at the protein level. The temporal appearance of CPEB1
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during post-natal development will be assessed with the aid of real-time PCR for mRNA
and with Western blots and immunocytochemistry for protein. The potential targets of
CPEB 1 will be identified from nucleotide and protein databases using a bioinformatics
tool in combination with rapid amplification of cDNA ends (RACE)-PCR. Several
candidates will be assayed with the aid of the polyadenylaiton test (PAT) to demonstrate
their status of polyadenylation in the paradigms of a light-dark period as well as during
postnatal development.

Aim 2: To characterize the expression of CPEB3 in the retina.
Specifically, this aim will explore isoforms of CPEB3 mRNA and protein; the types of
cells that express CPEB3, and the regulation of CPEB3 during postnatal development.
Bioinformatic analysis will be used to identify current known CPEB3 transcript variants
and protein isoforms. RT -PCR will be used to characterize the tissue distribution of each
isoform in the retina and in multiple other tissues. In situ hybridization and
immunofluorescence microscopy will be used to determine the localization of CPEB3
mRNA and proteins, respectively. Real-time PCR and Western blots will be used to
investigate the regulation of CPEB3 transcripts and proteins during post-natal
development.

Aim 3: To compare CPEB1-4 in the retina.
Specifically, this aim will investigate the types of cells that express mRNAs for CPEB1-4;
the temporal appearance of CPEB1-4 during postnatal development, and the relative
expression levels of CPEB1-4 in the retina. Comparison of the localization of four
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CPEBs in the retina will be performed with the aid of in situ hybridization. Comparison of
the appearance of all four CPEBs during post-natal development will be performed with
the aid of real-time PCR. Cross-comparison quantification with the aid of real-time PCR
data will be used to assess the relative abundance of CPEB 1-4.
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CHAPTER III
MATERIALS AND METHODS

1. Animal handling and tissue preparation

All animal experiments were carried out in compliance with the National Institutes of
Health Guide for the Care and Use of Laboratory Animals, the University of Louisville
Institutional Animal Care and Use Committee (IACUC) animal care regulations, as well
as the Association for Research in Vision and Ophthalmology (ARVO) statement for the
use of animals in ophthalmic and vision research.

C57/BL6 mice were used for this study (Charles River Laboratories, Davis, CA). Mice at
the age of postnatal day 1, 7, 12, 14, 16, 30, and 60 were used for developmental
studies. All the pups younger than 21 days old were raised together with their lactating
mothers. All animals were housed in normal diurnal cycles of 12-hour lighV12-hour dark
unless otherwisely specified. Each experimental group was composed of at least 5-6
animals.

For tissue collection, mice were euthanized with CO 2 followed by cervical dislocation.
For RNA and protein extraction, the eyes were removed; retinas were quickly dissected
and immediately frozen on dry ice before proceeding for extraction. Similar procedures
were followed when other tissues were collected for RNA extraction.
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For in situ

hybridization and immunohistochemistry, the eyes were removed and immediately fixed
in 4% paraformaldehyde for 12 hours at 4°C. The eyes were then transferred to PBS
buffer with 30% sucrose for dehydration for two weeks at 4°C. Snap-freezing technique
was used for the embedment: A stainless isopentane container was placed on dry ice.
Immediately before embedding, crushed dry ice was scattered in the isopentane until no
bubbles were generated from the mixture, an indication that the temperature reached
below -70 D C. The retina placed in tissue mounting medium in a mold was then floated
on the fluid (by holding the mold with a pair of forceps). Make sure that the mold was not
submerged in the isopentane/dry ice mixture.

The embedding process should take

several seconds. The mounted tissue was then cut on a cryostat the same day or frozen
air-tight at -SO°C for future processing.

2. Bioinformatic analysis - mRNA targets for CPEB1

In order to identify additional mRNAs potentially regulated by CPEB1, a bioinformatics
program, "CPE Motif Detector" was developed in collaboration with Dr. Eric Rouchka.
This program took into account the CPE motif, the presence of poly(A) signal sequence,
and a distance measure (spacer nucleotides) between those two. A database of 3' UTR
sequences was downloaded from UTResource (www.ba.itb.cnr.itlUTR/) and these 3'
UTRs were searched. Initial screens of CPE elements were found by looking for the
pattern TTTTTATT upstream of the poly-A signal AATAAA with a spacer sequence
between the two. For instance, if the expected spacer is between 50 and 100 bases, the
sequence can be searched using the Perl regular expression:

$seq =- "tttttatt(altlclgln){50,1 OO}aataaa")

70

In order to search for two or more CPE sites, the CPE motif was expanded to search for:

$seq =- "ttttt(alg)tt(altlclgln){1 ,}ttttt(alg)tt(altlclgln){1 ,}aataaa"

This pattern will allow alternative CPE motifs. Note, however, that this pattern does not
limit the range of the spacer between the two motifs, or between the second motif and
the poly-A signal.

3. Data mining -isoforms of CPEB3

UniGene database from NCBI databases (http://www.ncbLnlm.nih.gov) was used for the
identification

of

CPEB3

transcript

variants.

NCBI

and

Swiss-ProtlTrEMBL

(http://expasy.org/sprot/) databases were used for the identification of CPEB3 protein
isoforms.

Sequence alignments of transcripts and of proteins were carried out using

ClustalW

2.0.5

(http://www.ebLac.ukITools/clustalw2/);

sequence

alignments

of

transcripts with proteins were carried out using Vector NTI (Invitrogen, Carlsbad, CA);
sequence alignments of cDNAs with genomic DNA was carried out using UCSC mouse
genome Blat (http://genome.ucsc.edu).

4. Isolation of RNAs

Frozen retina was homogenized rapidly using PowerGen 250 homogenizer (Fisher
Scientific, Pittsburgh, PA). Total RNA was extracted using RNeasy mini kit (Qiagen,
Valencia,

CA)

following

the

manufacturer's

instructions.

Briefly,

tissue

was

homogenized for 10 seconds in an appropriate volume of lysis buffer, followed by chilling
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on ice.

This was repeated twice at 10 seconds each time.

The lysate was then

centrifuged at 14,000xg, and the supernatant was collected and transferred to a new
tube. One volume of 70% ethanol was added and the mixture was quickly loaded to
RNeasy spin columns and centrifuged briefly.

The columns were then washed with

buffer RW1 once, with buffer RPE twice, before RNA was eluted in RNase-free H20.

RNA concentration was determined using a BioPhotometer (Eppendorf, Westbury, NY).
The concentration of RNA was adjusted by dilution to an A260 within the range 0.1-1.0.
The concentrations of RNA samples were calculated based on the absorbance at 260nm
using the following equation:

RNA concentration (\1g/ml) = A260 x 40 x dilution factor

5\11 of each RNA sample was electrophoresed on an agarose gel. The quality of RNA
was determined from the ratio of 288/188 on agarose gel. RNA was frozen in -80·C for
long term storage.

5. Regular RT-PCR

0.2\1g of total RNA was used for every 20\11 RT reactions.

Omniscript reverse

transcriptase (Qiagen, Valencia, CA) and oligo-dT 15-mers were used to enable efficient
and sensitive reverse transcription.

Components were assembled using conditions

according to the manufacturer's suggestions; reactions were incubated for 60 min at
37°C.

1\11 of the cDNA was used for subsequent PCR. Hot8tarTaq DNA polymerase (Qiagen,
Valencia, CA) was used for robust and specific amplification.
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Components were

assembled according to manufacturer's instructions. The following settings of the
thermocycler were used:

Initial activation step: 95°C, 15min.
Amplification:
40 cycles of:

94°C,30sec;
55-60°C (approximately 5°C below Tm of primers), 30sec;
72°C,1min.

Final extension:

72°C, 10min.

Exon-exon spanning, gene-specific primers (lOT, Coralville, IA) were used for the
identification of CPEB1-4 and the positive control l3-actin transcripts (table 3).

Exon-

exon spanning, transcript specific primers were used for the identification of CPEB3
alternatively spliced variants (table 4). The Resultant PCR products were visualized on
1% agarose gel and photographed. Each specific band was purified from the gel and
sequenced for confirmation of its identity.

6. 3' RACE RT-PCR
Total RNA from mouse retina was used for 3' RACE RT-PCR. FirstChoice RLM-RACE
kit (Ambion, Austin, TX) was used for the amplification. An overview of the procedure is
illustrated in figure 17. Briefly, first strand cONA was synthesized from the retinal RNA
using the 3' RACE Adapter primer - an oligo-dT primer with an anchor sequence at the
5' end and degenerations at the 3' end (table 5). Specifically, degenerative oligo-dT
primers with an N and a V at the 3' end (V represents any of A, C, or G, while N
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Table 3. Primer sets used for CPEB1-4 and

~-actin

in regular RT-PCR

r.

Gene

Primer

Sequence

~-actin

fwd

5' -TGAAGATCAAGATCATTGCTCC-3'

rev

5' -TTAAAAAAACAAAGCCATGCC-3'

fwd

5'-CACCTTCCGTGTTTTTGGC-3'

rev

5'-ATCCCAGCATACACCACTCC-3'

fwd

5'-CTCTCAAGGGTCGTCTGAGC-3'

rev

5'-AATGCATAGCCTTTTGGTGG-3'

fwd

5' -CATCAAGGATAAACCGGTGC-3'

rev

5' -GAAGAATGGGGCAAACTTCC-3'

fwd

5'-ATTTTTCCTTTTCCGGAACG-3'

rev

5'-GTATCGTTCCACTCTCTCCCC-3'

CPEB1

CPEB2

CPEB3

CPEB4
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Table 4. Primers used to identify the alternatively spliced transcripts of CPEB3 in
regular RT-PCR

Gene

Primer name

Primer sequence

CPEB3

#1

5' -TGTCAATGTCGTTGTGTTGAAGTTGC-3'

#3

5' -GACTCCCACACCACAAGGATACACA-3'

#4

5' -GAAGGCGTCTTCAAAGGGAAAGAGA-3'

#5

5' -TATGATAAGGACTGACCATGAGCCTCTG-3'

#7

5' -AGGAGCTATGGGCGGAGACGA-3'

#8

5' -GCTGAGTCCCCAATGCCTTAGC-3'

#13

5' -CCCGTTTGTCAATGTCGTTGTGTT-3'

#16

5' -AAGGATAAACCGTTGAACTGGCA-3'

#17

5' -CATGAGCCTCTGAAAGGTAAACACT-3'

#18

5' -AAGACCGACCTCGTCTCCGC-3'

#19

5' -CATGAGCCTCTGAAAGGACGC-3'

#20

5' -GAAGACCGACTGTTAAGTGCCATA-3'

#21

5' -TTCGAGCTGTTGAACTGGCA-3'
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Figure 17. Diagram of 3' RACE

3' RACE (rapid amplification of cDNA ends)-PCR were used for the identification of CPE,
PAS-containing mRNAs from the mouse retina.
Oligo(dT) primers with anchor sequences attached to the 5' ends were used for the
reverse transcription. The resulted cDNA pool has a ubiquitous anchor sequence at the

3' end.
Nested PCR were used for the amplification. For the first round, forward primers
containing CPE consensus sequence paired with reverse primers - 3' outer primers (part
of the anchor region) were used. For the second round, forward primers containing PAS
consensus sequence paired with reverse primers - 3' inner primer (part of the anchor
region) were used. For both PCR reactions, the first 3-5 rounds were carried out with
annealing temperature at 3rC. The annealing temperature was raised to 60°C after that.
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3'

Table 5. Primers used for 3' RACE

Primer
3' RACE Adapter Primer
3' RACE Outer Primer
3' RACE Inner Primer
wobbled CPE
wobbled PAS

Sequence
5'GCGAGCACAGAATTAAT ACGACTCACT AT AGGT12VN3'
5'GCGAGCACAGAATTAAT ACGACT3'
5'CGCGGATCCGAATTAAT ACGACTCACT ATAGG3'
5'N14AAAATA3'
5'N14TTTATT3'

Note: The first three primers were from FirstChoice RLM-RACE kit (Ambion). It has an
anchor at the 5' end, as well as degeneration at the 3' end. V represents any of A, C, G;
whereas N represent any of A, C, T, and G.
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represents any of A, T, C, or G) make the annealing specifically occur where the poly(A)
starts, instead of randomly priming along the poly(A) tail. This primer helps to generate a
homogeneous 3' end (with respect to the length of the poly(A) tail) for the first strand
cDNA. M-ML V reverse transcriptase was used for reverse transcription and the
reactons were incubated at 40°C for 1 hour.
The cDNA was then used in two steps of nested PCR reactions: For the first PCR, 3'
RACE outer primer and a wobbled CPE primer were used; for the second PCR, 3' RACE
inner primer and a wobbled PAS primer were used. The 3' outer primer and the 3' inner
primer were complementary to the outer portion and inner portion of the 3' RACE
Adapter primer, respectively (table 5). The wobbled CPE primer and the wobbled PAS
primer have a random 14-mers in their 5' end, followed by sequences complementary to
CPE and PAS motifs, separately. A thermostable DNA polymerase was used for the
nested PCR. The following settings were used for the thermocycler:
Initial activation:

94°C,3min

Amplification:
3 cycles of:

94°C,30sec;
37°C,30sec;
72°C,30sec.

35 cycle of:

94°C,30sec;
60°C,30sec;
72°C,30sec.

Final extension:

72°C,30sec

Because the wobbled CPE and the wobbled PAS have only 6-nucleotide match, the first
three cycles of amplification was performed at a lower annealing temperature (3rC) to
79

ensure the sensitivity; the subsequent amplifications were performed at an annealing
temperature of 60°C to ensure specificity.
The PCR products were loaded to agarose gel for electrophoresis. The separated
bands were cut out, purified, and sequenced to identify their identity.

7. LM-PAT assay

Several methods to determine the length of poly(A) tails of mRNA are illustrated in figure
18. Since the amount of RNA from mouse retinas was limited, we avoided the methods
involving Northern blots. We used the ligation-mediated polyadenylation test (LM-PAT)
assay for our study, which is briefly described below.

For ligation, -1119 RNA was mixed with 5'-phophor-(dT)15-mer and denatured at 65°C
for 5 min, then transferred to 42°C without ice-quenching step. A mix of T4 ligase
(Promega, Madison, WI) with SuperScript" buffer, dNTPs and ATPs were prewarmed at
42°C then added to the RNA-primer mix, and incubated at 42°C for 30min. At the end of
incubation, appropriate amount of oligo(dT)-anchor primers was added and the tube was
transferred to 16°C for 2 hours.

For reverse transcription, the tube was transferred to 42°C for 2min. SuperScript"
RNase H- reverse transcriptase (Invitrogen, Carlsbad, CA) was added and incubated at
42°C for 1 hour. Afterward, ligase and reverse transcriptase were inactivated by
incubating at 65°C for 20min.

PCR was performed using HotStarTaq (Qiagen, Valencia, CA). The cDNA from the
above ligation and RT reactions, gene-specific primers, and anchor primers (table 6)
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Figure 18. Determination of poly(A) length (Salles et al. 1999)
a) Northern blot. The RNA molecule with longer poly(A) tail migrates at a slower
rate.
b) Oligo(dT)/RNase H Northern. Poly(A) tails are annealed to Oligo(dT) before
RNase H treatment, which removes RNA:DNA hybrid - the complete poly(A).
RNase H treated samples are compared to untreated samples in the subsequent
Northern blot. An approximate length of poly(A) tail can be inferred with this
method.
c) Rapid amplification of cDNA ends-PAT (RACE-PAT): Oligo(dT) primers with
anchors sequence attached to the 5' ends are used for reverse transcription
reaction. A gene-specific primer and an anchor primer are used for the following
PCR reactions. The mRNA with a longer poly(A) tail will generate a longer
smear (a mixture of amplicon with partial or full-length poly(A) tail).
d) Ligation mediated PAT (LM-PAT): Oligo(dT) primers and oligo(dT) primers with
anchor sequences attached to the 5' ends are used. A ligation step is performed
before the reverse transcription reaction to ligate these oligo(dT) together. A
gene-specific primer and an anchor primer are used for the subsequent PCR
reactions. The amplicons generated using this method is less heterogeneous
compared to c). The position of the smear on the PCR gel reflect the relative
length of the poly(A) tails.
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Table 6. Primers used for PAT assay

General primers

anchored oligo-dT primer

5'GACTCGAGTCGACATCGATTTTT I I I I I I 13'

anchor-only primer

5'GACTCGAGTCGACATCGA3'

5' phosphorylated oligo-dT

/5'PhosITTTTTTTTTTTTTTT3'

Gene specific primers

BDNF pat

5'CGTTTCTGTTCGTTCTGGTTC3'

CaMKlla pat

5'GGGAGGGGAGAAGAGATGTC3'

MAPK1 pat

5'TGATGGTGTTATCCCAGTGC3'

Ppp2r1a pat

5'GTTCGGTTCCTCCTCTGTAGC3'

Ppp2r2b pat

5'TCAATGTTCCCCAACTCCC3'

IRBP pat fwd

5'TCCTCAGACACCTTACCTGG3'

TTR pat fwd

5'TCTCCCCTGCTCCTAAAACC3'

Note: Anchored oligo-dT primers and 5' phosphorylated oligo-dT primers were used for
the reverse transcription step; anchor-only primers and gene-specific primers were used
for the PCR step.
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were assembled according to the manufacturer's instructions. PCR was run at the
following conditions:
Initial activation:

95°C, 15min.

Amplification:
35 cycles of:

94°C,30sec;
60°C, 30sec;
72°C,30sec;

Final extension:

72°C, 10min.

The PCR products were separated via agarose gel electrophoresis. The length of
poly(A) tails was indicated by the length of the smear.

8. Quantification of mRNA: real-time PCR

0.2119 of total retinal RNA from each of the seven developmental ages was used for
reverse transcription in preparation of cDNA for subsequent real-time PCR.

High

capacity cDNA archive kit (Applied Biosystems, Foster City, CA) was used for the
reverse transcription to ensure quantitative conversion of RNA to cDNA. Components
were assembled according to the manufacturer's protocol. The following temperature
and time conditions were used to achieve optimal conversion:
25°C

10min;

37°C

2hour.
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The resulted cDNA was diluted 1:20 and 5ul of the dilution was used for each real-time
PCR reaction that follows. The Gene Expression Assays - the mixture of gene-specific
primers and gene-specific, FAM-Iabeled probes, were optimized to ensure similar
amplification efficiencies (Applied Biosystems). 2x PCR master mix containing Taq DNA
polymerase, dNTPs and optimized reaction buffer was used (Applied Biosystems). 188
was used as the endogenous control. PCR reactions were performed on ABI 7300 realtime PCR system with the following conditions:
50°C

2min

95°C

10min

40 cycles of:
94°C

15sec

60°C

1min

Data was analyzed using 8082.1 software (Applied Biosystems). RNA quantity for each
sample was first normalized to the quantity of 188 in the same sample, and then
calibrated to postnatal day 1 (P1) sample to get the relative fold change.

The

manufacturer's IDs of Gene Expression Assays for each gene are listed in table 7. The
locations that the CPEB3 Gene Expression Assay matches on each transcript variant
are listed in table 8. The primers-probe set generates a product spanning two adjacent
exons which represents all known CPEB3 transcription isoforms.

9. In situ hybridization

121lm frozen sections were used for in situ hybridization. For each gene, sense RNA
probe (the complementary sequence of the antisense RNA probe) was used as negative
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Table 7. Gene Expression Assays used for real-time PCR

Gene Expression Assay

CPEB1
CPEB2
CPEB3
CPEB4
188
BDNF
CaMKlla
Mapk1
Ppp2r1 a (PR 65)
Ppp2r2b (PR 52)
Rbp3
Transthyretin

Catalog number

Mm00483970_m 1
Mm00616244_m 1
Mm01204296_m1
Mm00470951_m1
Hs99999901_s1
Mm01334047_m1
Mm00437967_m 1
Mm00442479_m1
Mm00772799_m 1
Mm00511698_m1
Mm00450075_m 1
Mm00443267_m 1

Note: the _m in the catalog numbers indicate that the primers/probe set only amplified
mRNA; while the _s indicates that the primer/probe set amplifies within a single
exon, so it does not distinguish genomic DNA from mRNA.
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Table 8. Match locations of CPEB3 Gene Expression Assay on each CPEB3 transcript

Gene Accession

Exon Boundary

Assay Location

Amplicon Length

NM_198300.2

4-5

1084

79

AK029261.1

4-5

1144

79

AK044639.1

4-5

1264

79

AK044639.1

4-5

1084

79

AB093274.1

4-5

1191

79

AK147243.1

4-5

1552

79

AK161513.1

4-5

1238

79

BC128377.1

4-5

676

79
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control. Primers (lOT, Coralville, IA) used in PCR amplification to generate the template
for probes are listed in table 9. PCR products were visualized on agarose gel and the
specific band was cut out and purified using QIAquick Gel Extraction Kit (Qiagen,
Valencia, CA).

The identity of the purified product was confirmed by sequencing

analysis, which was later used as template for in vitro transcription to generate OIGlabeled RNA probes (Invitrogen, Carlsbad, CA). RNA probes were denatured at 85°C
for 5 minutes then chilled on ice.

Slides were treated with 0.1 M RNase-free

triethanolamine (TEA)-HCI pH 8.0 for 5 min, washed, and pre-hybridized at room
temperature for an hour in hybridization buffer, which was then replaced with
hybridization solution containing 100-200nglml of RNA probes for overnight incubation at
65°C.

On the second day, slides were washed in 0.2xSSC several times then

transferred to buffer B1 (0.1 M Tris, 0.5M NaCI, pH7.5) for 5 minutes. Slides were then
incubated in buffer B2 (buffer B1 with 10% heat-inactivated sheep serum) for 1 hour at
room temp, after which buffer B2 was replaced with buffer B2 containing anti-DIG
antibody (1 :5000) for overnight incubation.

On the third day, slides were washed,

equilibrated in buffer B3 (0.1 M Tris, 0.1 M NaCI, 50mM MgCI2, pH9.5), and colorization
reaction was carried out in buffer B4 (buffer B3 with 201l1/mi NBT/BCIP stock solution
and 0.1 % tween-20).

Slides were then mounted in Mowiol mounting medium for

observation under the microscope.

10. Isolation of proteins

Frozen retina was homogenized using a sonicator (Biologics, Manassas, VA).
Appropriated amount of pre-chilled CelLytic MT Lysis buffer (Sigma, St. Louis, MO) with
1% (v/v) protease inhibitor cocktail (Sigma) was added to the frozen tissue. Sample was
immediately homogenized on ice at a moderated pulse and moderate power level.
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Table 9. Primers used for in situ hybridization

Probe

Forward primer

Reverse primer

CPEB1antisense

5'T AGCAATGCCAAT ATCTTTCGAAGG
3'

5'GTAAT ACGACTCACTATAGGG
TGGTCTGATCCAGAGCTGAA3'

CPEB1- sense

5'GTAAT ACGACTCACTATAGGGT AG
CAATGCCAAT ATCTTTCGAAGG3'

5'TGGTCTGATCCAGAGCTGAA3'

CPEB2antisense

5'TGAGCAGCCAGAAGAGGAAAGAGT
T 3'

5'GTAAT ACGACTCACTATAGGG
TGTGTT ACT ATTGTTGTCTG3'

CPEB2- sense

5'GTAATACGACTCACTATAGGGTGA
GCAGCCAGAAGAGGAAAGAGTT 3'

5' TGTGTT ACT ATTGTTGTCTG3'

CPEB3antisense

5' ACAGAGCCAGCTGCGCAAACCA3'

5'GTAAT ACGACTCACTAT AGGG
GAAGGTGCCTCCGAAGACCG3'

5'GT AAT ACGACTCACT ATAGGG
ACAGAGCCAGCTGCGCAAACCA3'

5'GAAGGTGCCTCCGAAGACCG3'

CPEB4antisense

5'GGAGGAAAGACGTGAGACATTAGG
T 3'

5'GTAAT ACGACTCACTAT AGGG
TGTCAACACTGGTGATTCAA3'

CPEB4- sense

5'GT AATACGACTCACTATAGGGGGA
GGAAAGACGTGAGACATTAGGT 3'

5' TGTCAACACTGGTGATTCAA3'

CPEB3- sense

Note: The sequences in bold is T7 promoter.
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Samples were then centrifuged at 4°C at 1000xg for 10 minutes to remove tissue debris.
Supernatant were collected and transferred to new tubes.

Protein concentration was determined using Bradford assay (Sigma, St. Louis, MO).
Briefly, BSA standard (Sigma) of 0.125mg/ml to 2.0mg/ml was used to generate the
standard curve.

An R2 >=0.99 for the standard curve was considered acceptable.

Several dilutions were used for unknown samples. Original concentration of the retina
samples were calculated based on the diluted readings that fell within the range of the
standard curve. The samples were then dispensed into aliquots and stored in -80°C.

11. Immunofluorescence microscopy

121lm frozen sections were used for immunohistochemistry. All steps were carried out at
room temperature. Sections were treated with TBS with 0.05% Triton for fifteen minutes,
and then blocked with 10% normal donkey serum in TBS for 1 hour. Sections were then
incubated with the primary antibodies at the indicated concentrations (table 10) for 1
hour. After several washes, fluorescence-conjugated secondary antibodies were applied
and incubated for 1 hour. Slides were washed again and subsequently cover-slipped in
Vectashield mounting medium (Vector Laboratories, Burlingame, CA) and observed
under Fluoview confocal microscope (Olympus, La Jolla, CA). Negative controls with
primary antibodies omitted were used for all experiments.

Negative controls with

primary antibodies pre-adsorbed with an immunogenic peptide or recombinant proteins
were applied when possible.
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Table 10. Antibodies used for immunofluorescence

Antibodies
CPEB1

CPEB3

Catalog and Company
Custom antibody
Affinity Bioreagents
Ab10883
Abcam

Work Concentration
1:30,000

1:1000

GAPDH

Img-5019A
Imgenex

1:5000

HRP conjugated secondary
antibody, goat anti rabbit

AP187P
Millipore

1:30,000

HRP conjugated secondary
antibody, goat anti mouse

AP130P
Millipore

1:30,000
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12. Recombinant proteins

The cDNAs of full-length CPEBs were cloned into pGEX2T vector with a glutathionine Stransferase (GST) tag at the 5' end. The plasmid was transformed to E. coli B21 cells
(Keyclone, Cincinnati, OH). For the expression of the proteins, B21 cells were cultured
in Luria Broth (LB) medium at 37°C until the 0.0. 600 reached 0.4. Then isopropyl 13-01-thiogalactopyranoside (IPTG) was added to the culture to a final concentration of
0.8mM. Cells were allowed to grow for several hours. When the 0.0.600 reached 1.53.0, cells were harvested and proteins extracted using B-PER bacterial protein extraction
reagent (Pierce, Rockford, IL). Total proteins (soluble and insoluble proteins altogether)
were loaded to polyacrylamide gel electrophoresis (PAGE) gel and stained with
Coomassie Blue. The extra band presented in the induced samples compared to the
non-induced was purified with the aid of immunoprecipitation. The sequence of the
purified band was confirmed by mass spectrometry.

CPEB proteins were predominantly expressed as insoluble forms in inclusion bodies. In
order for the recombinant proteins to be used for antibody pre-adsorption, they must be
solubilized. Therefore, the following treatments were performed: First, inclusion bodies
were purified from the whole cell lysate using B-PER bacterial protein extraction reagent
(Pierce); secondly, they were solubilized in Inclusion Body Solubilization Reagent
(Pierce); and lastly, solubilized proteins were returned to physiological conditions via
dialysis. A brief description of each step was as follows:

For the purification of inclusion bodies, induced culture was collected and centrifuged at
5000xg for 10min. Appropriate amount of Bacterial Protein Extraction Reagent (B-PER)
with 1:100 (v/v) proteases inhibitors (Pierce, Rockford, IL) was added to the pellet (cells).
Cells were lysed and homogenized by pipetting and vortexing until the suspension was
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homogeneous. The homogenate was centrifuged at 15,OOOxg for 15min at 4°C to
separate soluble proteins and insoluble proteins. Appropriate amount of B-PER was
added to the pellet (inclusion bodies) and resuspended. Lysozyme was added to a final
concentration of 2001lg/ml followed by 5min incubation at room temp. 1: 10 diluted BPER was added to the tube, vortexed and centrifuged at 15,OOOxg for 15min. Pellets
was collected, resuspended in 1: 10 B-PER and centrifuged. This step was repeated two
more times. The pellet was collected for further treatment.

For solubilization, the pellet of purified inclusion body was resuspended in appropriate
amount of Inclusion Body Solubilization Reagent by vigorous vortex or by pipetting. The
suspension was shaken for 30min and centrifuged at 27,OOOxg for 15min to remove cell
debris. The suspension was the solubilized proteins from the inclusion body. Because
the Inclusion Body Solubilization Reagent contains high amount of strong denaturant,
proteins in this buffer have to be dialyzed before they can be used for antibody preadsorption.

Dialysis was performed at 4°C to maintain protein stability. Solubilized protein samples
were put into Slide-A-Lyzer cassettes (Pierce) of appropriate molecular cutoff.

The

cassette with sample was put in 1L of 6M urea and dialyzed for 6 hours. 250m I of 25mM
Tris·HCI (pH7.5) was added to the container every 6-12 hours, until the volume reached
3L.

The dialysis solution was then replaced with 2L of 25mM Tris·HCI (pH7.5) and

150mM NaCI, followed by another 6-hour dialysis. The sample was removed from the
cassette and centrifuged to remove any insoluble material.

The concentration of the

supernatant (the soluble recombinant protein) was determined using Bradford Assay
(Pierce). The sample was then ready for use in antibody pre-adsorption.
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13.lmmunoprecipitation
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10 mg of total protein from the retina, 10l1g of CPEB3 antibody, and S0l11 SO% protein A
plus

slurry

(Thermo

Fisher

Scientific,

Rockford,

IL)

were

used

for

each

immunoprecipitation reaction. PBS buffer (NaCI 1S0mM, phosphate 10mM, pH7.4) was
used as wash/binding buffer.

The protein sample and the antibody were mixed and

incubated on a rotator at 4·C for 3 hours.

Protein A plus beads (SO% slurry) were

washed three times in PBS and added to the antigen-antibody mixture and incubated on
a rotator at 4·C for overnight. The complex was centrifuged at 2SOOxg for 3 minutes,
washed three times with PBS, and reconstituted in 30-S0111 2x Lamilli sample loading
buffer. The complex was then heated at 9S·C for S minutes, and analyzed by gel
electrophoresis.

Gel was stained with Gel Code Blue (Thermo Fisher Scientific,

Rockford, IL) and destained with water, then cut into several portions for mass
spectrometry.

14. Quantification of proteins: Western blotting

2SI1g of total protein from each sample was used for Western blots. Protein standards of
10kO to 2SOkO (Thermo Fisher Scientific, Rockford, IL) was used as markers.

2x

Laemmli buffer (Sigma, St. Louis, MO) was added to the samples and boiled at 9SoC for
Smin. Samples were loaded to SOS-PAGE for gel electrophoresis. Proteins were
transferred from the gel to O.4Sl1m polyvinylidene fluoride (PVOF) membrane using a
Semi-dry transfer apparatus (Biorad, Hercules, CA). The blots were blocked with 10%
milk for 1 hour, before primary antibodies were added for overnight incubation at 4°C.
The blots were washed in TBS with 0.3% tween-20, and then incubated in secondary
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antibody for 1 hour at room temp. The blots were washed thoroughly before enhanced
chemiluminescence reagent (Thermo Fisher Scientific, Rockford, IL) was used to detect
the signal. The source and dilutions of the primary and secondary antibodies used are
listed in table 11. Recombinant proteins or immunogenic peptides were used to preadsorb the antibody at a ratio of 10:1 (mass/mass) to demonstrate the specificity of the
antibody.
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Table 11. Antibodies used for Western blots

Antibodies

Catalog and Source

CPEB1

Custom antibody
Affinity Bioreagents

CPEB3

Ab10883
Abeam

Map1a

ChAT

Alexa Fluor® 594
donkey anti-rabbit IgG
(H+L)
Alexa Fluor® 488
donkey anti-mouse IgG
Alexa Fluor® 488
donkey anti-goat IgG

Work Concentration
1 :400

1:50

1:200

M4278
Sigma

1 :200

AP144-p
Millipore

1:200

A21207
Invitrogen

1:200

A21202
Invitrogen

1 :200

A11055
Invitrogen
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CHAPTER IV
RESULTS

1. CPEB1 expression and regulation

One previous study reported the presence of CPEB1 mRNA in the mouse retina using
PCR (Liu et al. 2000).

In this study we set out to confirm this initial observation.

Additionally, we set out to demonstrate the localization of CPEB1 mRNA and protein in
the mouse retina; the expression patterns of CPEB1 during postnatal development of the
retina; and potential mRNA targets for CPEB1 in the retina.

To confirm the previous finding, we first performed regular RT-PCR using a set of
primers that were different from the prior study. We used total RNA collected from the
retinas of adult mice. The primers we used for CPEB1 had low homology with the other
three known CPEBs, and had no significant homology to any other gene. The amplified
band was cut out and sequenced for validation.

~-actin

primers were used as a positive

control and a negative control; the latter had all the components except that the reverse
transcriptase was omitted in the RT step. The result demonstrated that CPEB1 mRNA is
expressed in retina of the adult mouse (figure 19). The absence of signal in the negative
control indicated no contamination in any component of the RT or PCR steps, or during
the setup of these reactions.
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Figure 19. Presence of CPEB1 mRNA in the retina
Total RNA from postnatal day 30 mice retina was used. Regular RT-PCR was
conducted using CPEB 1 primers that span exons to exclude amplification of genomic
DNA. l3-actin was used as a positive control. A reaction with only reverse transcriptase
omitted for reverse transcription but with all the other components for RT and PCR (with
l3-actin primers) was used as a negative control. The amplified band was sequenced for
confirmation. The results demonstrated the presence of CPEB1 mRNA in the mouse
retina.
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Figure 19
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1) Localization of CPEB1 mRNA
Next, we explored the localization of CPEB1 mRNA in mouse retina with the aid of
in situ hybridization. Antisense RNA probes were made with primers specifically

designed for CPEB 1. The sense RNA probe from the same region was used as a
negative control. Amplified templates of both antisense and sense probes were
sequenced to confirm the specificity. The clean background in tissue probed with
sense probe indicated the specificity of the anti-sense hybridization (figure 20
upper panel). Results in tissue hybridized with antisense probe demonstrated that
CPEB1 mRNA is predominantly localized in the inner retina, particularly in the
RGC layer, and to some extent, the inner part of the INL (figure 20 lower panel).
The IPL and OPL appeared to be positive for CPEB1 as well, but the synaptic
structures of these layers could not be distinguished at this point due to the
limitation on the resolution of in situ hybridization techniques. The localization of
CPEB1 protein would be further explored using immunofluorescence microscopy
(see below).

2) Developmental regulation of CPEB1 mRNA

The next question concerned the possible regulation of CPEB1 mRNA. To explore this
issue mRNA levels were compared during postnatal development with the aid of realtime PCR. Total retinal RNAs from seven developmental ages which included the eyeopening event (approximately day 14 in mice) were used. Taking into consideration that
physiological responses of the retina to ambient light might cause circadian regulation of
certain genes, all the tissues were collected at the same time of the day. Both the
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Figure 20. Localization of CPEB1 mRNA in the retina
P60 mouse retina was used for in situ hybridization. Mouse CPEB1 primers were
designed with low homology to the other three CPESs and to any other mouse genes.
The primers were used to make the antisense probe of about 500bp-long whose identify
was confirmed via sequencing. The sense probe at exactly the same location was used
as a negative control. The results indicated that CPEB1 is highly expressed in RGC
layer, and to a less extent, in the INL, especially inner layers of INL. CPEB1 mRNA also
appeared to be present in the plexiform layers. Due to the limitation on the resolution of
this method, we could not identify synaptic structures in the plexiform layer at this point.
The calibration bar represented 50 11m.
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Figure 20
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CPEB1 primer set and the 6-carboxyfluorescein (FAM)-Iabeled CPEB1 probes (Applied
biosystems) were gene-specific which ensured stringent specificity.

Our data demonstrated an up-regulation in the level of CPEB1 mRNA throughout the
period of postnatal development into adulthood (figure 21).

A significant increase

(p<0.05) of 2.5 fold was observed in P12 compared to P1. No significant changes were
found between P12 and p16. Whereas the older animals, P30 and P60, demonstrated
another significant increase compared to P14 and P16, respectively.

The overall

increase in the level of CPEB1 transcripts was about 6 fold in adult animals (P60)
compared to newborns (P1). The data appeared to be consistent with the notion that
some aspect of development regulates CPEB1 transcription. The data are less clear as
to whether eye opening makes any significant impact on the course of this
developmental regulation.

3) Localization of CPEB1 protein in the retina

To confirm and extend the observations from the in situ hybridization data, fluorescence
immunocytochemistry was performed with an antibody to CPEB-1 on fixed tissue
sections of the retina. The results of these studies indicated that CPEB1-protein is
clearly located in the neuronal processes that make up the inner plexiform layer. At
least two laminar structures are distinguishable in the INL (figure 22, 23). Cell bodies in
the RGC layer are immunopositive for CPEB1 and some cell bodies in the INL are
immunopositive for CPEB1.

To identify the cell phenotypes expressing CPEB1, we used double labeling, combining
CPEB1 antibody with a retinal ganglion cell marker MAP1a (Okabe et al. 1989; Tucker
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Figure 21. Developmental pattern of CPEB1 mRNA
Total RNA from the retinas of postnatal day1, 7, 12, 14, 16, 30, and 60 which were
collected at the same time of the day was used for real-time PCR assays. The
combination of gene-specific primers and FAM-Iabeled gene-specific probes ensured
high specificity. 18S was used as an endogenous control. The relative fold changes
were acquired by calibrating all the older ages to age P1. Each age had 6-10 animals.
The Anova procedure, Tukey's Studentized Range (HSD) was used for statistics. Error
bars indicated standard deviation (SO). Significant changes were found between each
two bracketed ages (p<0.05). The results demonstrated an overall up-regulation of
CPEB1 transcripts during postnatal development. A significant increase (2.5 fold) was
found in P12 compared to P1. P12-16 showed no significant changes. The level of
CPEB1 mRNA continued to increase significantly from P16 until the adulthood (P60).
The overall increase of CPEB1 transcripts from P1 to P60 was about 6 fold.
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Figure 21
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P60

Figure 22. Localization of CPEB1 protein - with MAP1 a
P16 retina was used for the immunohistochemistry. CPEB1 was expressed in some
cells in the retinal ganglion cell (RGC) layer. The double labeling of CPEB1 and MAP1a
demonstrated that some CPEB1 positive cells were MAP1a positive (arrows); while
other CPEB1 positive cells in RGC layer were MAP1a negative (arrowheads). This
indicated that some, but not all, CPEB1 positive cells in the RGC layer were ganglion
cells. The MAP1 a labeling in outer plexiform layer (OPL) was non-specific since it also
appeared in no primary negative controls. CPEB1 was also highly expressed in the
inner plexiform layer (IPL), with some laminar pattern. A few cells in the inner nuclear
layer (INL) were CPEB1 positive. The scale bar represented 50 11m.
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Figure 23. Localization of CPEB1 - with ChAT
P16 mouse retina was used for immunohistochemistry. CPEB1 was expressed in some
cells in the retinal ganglion cell (RGC) layer. The double labeling of CPEB1 and ChAT
demonstrated that some CPEB1 positive cells were ChAT positive (arrows); while other
CPEB1 positive cells in RGC layer were ChAT negative (arrowheads). This indicated
, that some, but not all, CPEB1 positive cells in the RGC layer were displaced amacrine
cells. CPEB1 was also highly expressed in the inner retina, with some laminar pattern.
The two distinguishable laminae ( small open arrows) appeared not to be co-localized
with ChAT, suggesting that they were not cholinergic synapses. The close juxtaposition
of these two laminae with ChAT positive laminae raised the possibility that they may be
localized in sublamina a and sublamina b respectively. A few cells in the inner nuclear
layer were CPEB1 positive, some being ChAT positive (big open arrows), and others
ChAT negative (big open arrowheads). This suggested some of the CPEB1 positive
cells in the INL were cholinergic amacrine cell, the others were not. The scale bar
represented 50 11m.
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and Matus 1988), or a cholinergic amacrine cell marker choline acetyl transferase (ChAT)
(Kang et al. 2004; Eckenstein and Thoenen 1982; Voigt 1986; Zhang et al. 2005). Our
data demonstrated that the CPEB1 positive cells in RGC layer can be MAP1a positive
(figure 22), or ChAT positive (figure 23). This suggested that some CPEB1 positive cells
in the RGC layer are retinal ganglion neurons, and some are displaced amacrine cells.
Some, but not all CPEB1 positive cells in the inner layers of INL are ChAT positive,
indicating that some of those cells are cholinergic amacrine cells. The CPEB1+/ChATcells in the INL could be other types of amacrine cells, or bipolar cells. To determine all
phenotypes of cells expressing CPEBs would require an extensive study of double and
triple antibody labeling with antibodies to known cell markers which is beyond the scope
of this dissertation.

CPEB1

immunolabeled tissue

development.

sections showed distinguishable

patterns during

Throughout all developmental ages examined, CPEB1 was highly

expressed in the IPL.

The labeling of CPEB1 was across the IPL, but some

distinguishable laminar structures were labeled at a higher level.

These laminar .

structures did not appear to co-localize with ChAT labeling (figure 23). This suggested
that these synaptic layers are not cholinergic. However, these CPEB1 positive laminae
are within close proximity to the ChAT positive laminae. A dark "furrow" lay between two
laminar structures in the CPEB1 staining.

4) Developmental regulation of CPEB1 proteins in the retina
To expand our observation of the developing pattern of CPEB1 mRNA, we looked at the
levels of CPEB1 proteins during development with the aid of Western blots. To validate
the specificity of the antibody, the immunogen, a peptide used to generate the antibody
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was used in pre-adsorption experiments as the negative control (figure 24b). The results
from Western blots (figure 24a) indicated that qualitatively the level of CPEB1 protein
was up-regulated in the retina during the postnatal development, which is consistent with
our observation on the developmental pattern of CPEB1 mRNA (figure 21).

5) Identification of CPE-containing mRNAs in mouse database using a bioinformatics
program
Two consensus sequences for CPEs in mRNAs that contain such regulatory sequences
have been published. These include: UUUUUAU and UUUUAAU (Fox et al. 1989;
Simon et al. 1992). However, very few gene-transcripts are known targets of CPEB1 in
the central nervous system. To identify potential mRNA targets of CPEB1 using the
current knowledge of CPE sequences, two approaches were used to explore this
relatively new area. The approaches adopted included the use of a home-grown
bioinformatics program, and the use of a specialized 3' RACE RT-PCR.
The bioinformatics program was designed with the help and collaboration of Dr. Eric
Rouchka in the Department of Computer Engineering and Computer Sciences and
named "CPE Detector". This program searched the 3' UTR databases UTRdb
(www.ba.itb.cnr.itlUTRI) for the presence of the CPE consensus motif, the PAS
consensus motif, the relative location of the two (CPE may partially overlap with PAS,
but is always upstream of PAS), and the length of the gap between the two. Genes with
the required characteristics were retrieved and classified into different categories based
on the length of the gap (table 12). Several redundant or non-redundant databases
ranging from fungus to human were used. From the non-redundant mouse 3'UTR
database, we identified a total of 1449 genes that have at least one CPE upstream of the
111

Figure 24. Developmental pattern of CPEB1 protein
a) Total retinal proteins of P1-P60 mice were used for western blots. Qualitatively
the level of CPEB1 protein in the retina was up-regulated during postnatal
development. This is consistent with real time PCR data.
b) To ensure the specificity of the antibody, synthetic immunogenic peptide was
used to pre-absorb the antibody before applying the antibody to the blot. Preadsorption diminished the band which suggested that the detected band was
specific for CPEB1.
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PAS. Among them 185 genes have a gap of 10-50bp, 190 have a gap of 51-1 OObp; 127
have a gap of 10 1-150bp; 103 have a gap of 151-200bp. About 1100 genes have a gap
longer than 201 bp.
With the aid of the mouse UTR database (www.ba.itb.cnr.itlUTR/). we further screened
for genes with two or more CPE motifs upstream of the PAS. After refinement of this
program, 1045 genes with two CPE motifs and one poly(A) site in their 3' UTRs were
identified; only 36 with a spacer of less than 250bp (table 13). Some of the genes
thought to be likely candidates were subjected to polyadenylation tests (PAT) (table 14).

6) 3' RACE-PCR to identify CPE containing mRNAs specifically from mouse retina
To identify the potential retinal mRNAs with CPE and PAS in their sequences, a
specialized 3' RACE RT-PCR method was developed. Total mouse retinal RNAs were
used in two rounds of nested 3' RACE PCA. The first round amplified specifically CPEcontaining mRNAs; while the second round amplified, in the population derived from the
first round of PCR, specifically PAS-containing mRNAs. A highly repeatable pattern was
acquired with this method (figure 25). Each distinguishable band was cut out, purified,
and sequenced. The identities of these sequences were determined by comparing their
sequences to the nucleotide database using Blastn
(http://blast.ncbi.nlm.nih.gov/Blast.cgi).
One of the possible limitations of this method was that it did not distinguish CPE/PAS
within the 3' UTR from CPE/PAS within the other regions of the gene. After sequencing,
only one gene from these bands, transthyretin (TTR), truly had a CPE/PAS in its 3' UTA.
TTR encodes for a transport protein for retinol. Its mRNA has been localized in the
retinal pigment epithelium (RPE) cells. However immunoreactivity for TTR protein has
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Table 12. CPE-containing mRNAs identified using "CPE Detector" program

Number of genes identified from the databases using "CPE Detector" (developed in collaboration with Dr. Eric Rouchka). Redundant
(R) or non redundant (NR) 3' UTR databases for different organisms were used. Candidate genes extracted were categorized
according to the length of the gap between CPE and PAS. The results derived from mouse and rodent databases were highlighted.
#
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Table 13. List of mouse genes with two or more CPEs upstream of PAS (within 250 bp distance) in the 3' UTR

NUMBER

NAME

AB008811

N-cadherin

AF031903

Arl6

AF062567

Sp3

AY089967

Basigin 2

AY484583

VGFG2573

AY484585

VGFG2573

C006789

PREDOMINANTLY EXPRESSED IN

CNS?

Ets

BC022682
~
~

Q)

r BC024126

Dimethylglycine dehydrogenase precursor

BC026127

Csnk1 e (Casein kinase 1)

Nerve ganglia; prosencephalon; skin

yes

BC027797

Sp3 (Trans-acting transcription factor 3)

Mesencephalon; vascular tissue; lymph node

Yes

BC029814

Fos (FBJ osteosarcoma oncogene)

Bone marrow; bone; liver

yes

BC030726

Casc4 (cancer susceptibility candidate 4)

Nerve ganglia; prosencephalon; cerebellum

yes

BC031438

Extl2 (Exotoses (multiple)-like 2)

Basal ganglia; nerve ganglia; skin

yes

BC037478

Extl2 (Exotoses (multiple)-Iike 2)

Basal ganglia; nerve ganglia; skin

yes

BC040201

Zfp715 (Zinc finger protein 715)

Endocrine gland ; lymph node; whole brain

yes

BC048845

Inhbb (Inhibin beta-B)

Female genital; mammary gland; lung

Yes,·not top3

BC050916

Crsp3 (cofactor required for Sp1 transcriptional
activation , subunit 3

Blood; whole brain; ear

yes

Gent2 (Glucosaminyr(n-acetyl) transferase 2)

GalfllladCter; vascular; extraembryonic tissue

Yes (not top 3)

BC057182

Brd1 (Bromodomain containing 1)

Bone; whole brain; eye

Yes

BC057543

Lefl (Lymphoid enhancer binding factor 1)

Thymus; skin; spleen

small

C054845

. -~

BC060175

.....
.....
-...J

BC062954

Ehd2 (EH-domain containing 2)

Lymph node; vascular tissue; thymus; cerebellum

Yes

BC064446

Casc4 (cancer susceptibility candidate 4)

Nerve ganglia; prosencephalon; cerebellum

Yes

X69620

Inhbb (Inhibin beta-B)

Female genital; mammary gland; lung

Yes (not top 3)

M60803

NA

NA

NA

KOOO2O

Ifnb1 (Interferon beta 1, fibroblast)

NA

NA

AK129312

Crsp3 (Cofactor required for Sp1 transcriptional
activation, subunit 3)

Blood; whole brain ; ear

yes

AY435148

Gent2 (Glucosaminyl (N-acetyl) transferase 2)

Gall bladder; vascular; extraembryonic tissue

Yes (not top 3)

AY435149

Gent2 (Glucosaminyl (N-acetyl) transferase 2)

Gall bladder; vascular; extraembryonic tissue

Yes (not top 3)

AY435150

Gent2 (Glucosaminyl (N-acetyl) transferase 2)

Gall bladder; vascular; extraembryonic tissue

Yes (Rot top 3)

BCOO5508

Crsp3 (cofactor required for SP1 transcriptional
activation, subunit 3

Blood; whole brain; ear

yes

BC018497

Arl-6 (ADP-ribosylatlon factor-like 6)

Embryonic tissue; eye; limb

yes

BC040386

Zfp715 (zinc finger protein 715)

Endocrine gland ; lymph node; whole brain

yes

BC057313

Zfp715 (zinc finger protein 715)

Endocrine gland; lymph node; whole brain

yes

M31131

Cdh2 (cadherin 2)

Eye; whole brain; heart

yes

Table 14. Sequences and locations of CPE, PAS, and linker of eight CPE-containing mRNAs

Gene
name
Actin-beta

Accession
#

NM_007393

1st CPE
seguence
T6GT4G T4G

1st CPE
location
136213:nt

T4GT15G2T4 1488G TeT7 A2T
1536

T5-A2-T

1"722--

Hex
Seguence
TTTAAA

Hex
Location
13971802

TTTAAA

16901695

- AA,TAAA- -f862-

1729

1867

-"
-"

ex>

BDNF

CaMKlla

MAPK1

NM_007540

NM_177407

NM 011949

T4AT

15021507

T6.A T7 AT5

30293048

Linker Seq
CGCTTTTGACTCAGGA

AGTCATTCCAAGTATCCATGAAATAAGTGG
TTACAGGAAGTCCCTCACCCTCCCAAAAGC
CACCCCCACTCCTAAGAGGAGGATGGTCG
CGTCCATGCCCTGAGTCCACCCCGGGGAA
GGTGACAGCATTGCTTCTGTGTAAATTATG
TACTGCAAAAATTTT

Linker
size
16

154

TTCTGAATGGCCCAGGTCTGAGGCCTCCC
I I I I I I I IGTCCCCCCAACTTGATGTATGAA
GGCTTTGGTCTCCCTGGGAGGGGGTTGAG
GTGTTGAGGCAGCCAGGGCTGGCCTGTAC
ACTGACTTGAG

faa

TATAAA

15181523

GAACTGCATG

9

AAAAAG

30703075
13073aQ7§

GAGACATTTTGGGAAAAGGAAA(AAA)

22/25

IAAGAAA

-----------------------

T6AT

40284035

AGTAAA

40584063

AGTGATTCCCATTGAAACTGTA

22

T6A2T

46694677

AATAAA

47804785

CTGTGGCTGTGAACTTGAATGACCACTGCT
CAAACTTTCTGCTACTGGGGGGGTGGGGG
AGGGGAGAAGAGATGTCTGGTTTATTCTTG
GCGTTTTCAGTGG

102

T6GT3GT3G
T3GT5GT3G

48794909

AATAAA

49294934

CAAATCTCCCCTGTTGCAA

19

T~

'2~el;?t

AATAAA

2871-

GACATCAATGGAAAATGGGTTCTATAAAGA

78

T4GT4CT2G2 2763-

Ppp2r1a

Ppp2r2b

NM_016891

T5 AT6 AT4

2793

T6 G T gtgt

21802187

T5AT4AT2

22032215

AATAAA

22392244

NM_028392

seven nt off
compare to
NM 027531.

NM_027531

tgtg T4G T3

18181825

T10 A2 T

18881900

AATAAA

19451950

CTGCCTGCTAGTATGAACAGCAATGCAATG
CACTTGTAACTC
ATGGA
GTGTCAATTGTGCCA

52

CCTTTCCCTACTGTACACGGAGA

24

CTAG-GTGTCTCrCTCrC-GATAAAATGAGATTGTCTGTAGTATTTAAGGAGAAAAAGAGATAA

63

~~

TAAGCATTCCATTTGTTTGAAAAAAATCAAC
AACAAAAAAAAAA

45

RBP·3

NM_015745

T6A3

48424850

AATAAA

49204925

70

Ttr

NM_013697

GGAGGACCATGCACCTGTATTGTCTAGCCT
TGACATCTGGAAAGGCTAAGCTGTTGCTGC
TCAGGGCCT

T3 C T6 AT3

623-636

TTTAAA

674-679

CCTCATTTTTCTCCCCTGCTCCTAAAACCC
AAAATTT

38

T9AT

10061017

AATAAA

10331038

AACCTTTAGTGACTA

f5

......
......
<0

2876

Figure 25. RACE for identification of target mRNAs of CPEB1
Total P60 mouse retinal RNA was used for 3' RACE. An illustration of the 3' RACE
method is shown in figure 16. The used of wobbled CPE primers and wobbled PAS
primers in the nested 3'RACE reactions generated multiple bands. Each band was cut
Qut, purified, and sequenced to identify its identity.

120

Figure 25

1.5 1k b

1.0 1k b

800bp

500b;p

300bp

121

been found in RPE, the optic nerve fiber layer, as well as retinal ganglion cells of the
retina (Dwork et al. 1990). This gene, together with several of the genes identified using
the bioinformatic program, were used in polyadenylation assays (see below). Another
limitation on this method was that because of the competition for the same set of primers,
additional genes that have 3' UTR/PAS in their 3' UTRs may not be amplified to
sufficient amount for them to be identified from the gel or in our sequence data.

7) Polyadenylation of eight CPE-containing mRNAs in developing retina
The following eight genes, based on their known possession of CPE/PAS motifs in their
3' UTRs and the known or suspected presence in the retina, were selected for the PAT
assay: CaMKlla, BDNF, l3-actin, MAPK, protein phosphatase regulatory domain 1a
(Ppp2r1 a), protein phosphatase regulatory domain 2b (Ppp2r2b), interstitial retinol
binding protein (IRBP), and TTR. The number of copies and the sequences of CPE and
PAS motifs, as well as the sequence and length of gaps between the two in these eight
genes was confirmed (table 14).
The experimental paradigm chosen as a putative trigger for polyadenylation was
development. Total retinal RNA samples from mice of different ages were used for the
LM-PAT method. The length of the poly(A) tails were visualized on agarose gel (figure
26). The assays were repeated multiple times with consistent results indicating that
MAPK1, Ppp2r1A, Ppp2r2B, IRBP and BDNF mRNAs acquired elongated poly(A) tails
from P1 to P7. Ttr and BNDF had elongated poly(A) tails from P7 to P12. No profound
changes in the length of the poly(A) tails were found for these genes in older animals
(figure 26). The PAT which measures mRNA elongation provides supporting evidence
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Figure 26. LM-PAT assays of potential CPEB1 targets
Total RNA from seven ages of P1 to P60 retinas were used. An illustration of the LMPAT method is illustrated in figure 17. Eight genes: j3-actin, BDNF, CaMKlla, MAPK,
Ppp2r1 a (protein phosphatase 2 regulatory subunit A), Ppp2r2b (protein phosphatase 2
regulatory subunit B), IRBP (interstitial retinol binding protein), and TTR (transthyretin)
were selected based on the 3' RACE results and the bioinformatics program "CPE
Detector". GAPDH, which does not have any CPE sequence in its 3' UTR, was used as

a control.

The results demonstrated that from P1 to P7, six out of eight candidate genes

(except j3-actin and ITR) acquired prolonged poly(A) tail. From P7 to P12, TTR gained
prolonged poly(A) tail.
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that some aspect of development, especially between P1 and P7 triggers the
translational control apparatus.

In summary, our study confirmed the presence of CPEB1 in the mouse retina. The level
of CPEB1, both mRNA and protein, were up-regulated throughout development.
Potential mRNA targets of CPEB1 were identified both computationally and
experimentally. Several genes from the candidate pool acquired elongated poly(A) tails
during postnatal development.

2. CPEB3 expression, regulation and isoform analysis
Having demonstrated the expression patterns of the well established CPEB1 in the
mouse retina, we were particularly interested to see if CPEB3 is present in the retina.
One of the recently established target mRNAs for CPEB3, GluR2, has been shown to be
a key player in synaptic plasticity. Although much less is known about the mechanism
and the expression pattern of CPEB3 compared to CPEB1, it is postulated that CPEB3
functions through a mechanism that is distinct from that of CPEB1. It may also be rather
different from CPEB1 with regard to its tissue distribution and its mRNA substrate
specificity. The existing state of our knowledge concerning the isoform composition of
CPEB3 is summarized in a 2003 publication (Theis et al. 2003). Our goal in this section
was to first expand and update this knowledge of CPEB3 isoforms and their relative
tissue distribution, and then to establish the expression pattern of CPEB3 in the mouse
retina.

125

1)

CPEB3 has multiple unique motifs compared to CPEB1, 2 and 4.

Four CPEB paralogs (CPEB1-4) derived from four different chromosomes have been
identified in mouse. The N termini of CPEBs are profoundly variable, while the C termini
are highly conserved (Theis et al. 2003).

Sequence comparison demonstrates that

CPEB3 shares higher homology with CPEB2 and CPEB4, but is distal to CPEB1 in the
family tree. RNA recognition motifs (RRM) of CPEB3 share 97-99% identity with CPEB2
and CPEB4, but only 45% with CPEB1 (Theis et al. 2003).

Searching the complete

sequences of CPEB2, 3 and 4 proteins, we identified multiple sequences that are unique
to CPEB3, including a poly-glutamine (poly-Q) track, a serine-alanine (SA) track, a 23
amino-acid motif and an 8 amino-acid motif (figure 27).

They are also absent from

CPEB1. These motifs may have functional significance with respect to the uniqueness to
CPEB3.

2)

Multiple isoforms of CPEB3 were identified in the database using bioinformatics

analysis
A previous study characterized four different alternative splicing isoforms of CPEB3
transcripts (Theis et al. 2003), in which two short motifs of 69nt and 24nt (coding for 23
amino acids and 8 amino acids, respectively) are removed individually, or concurrently.
However, the structure of CPEB3 seems to be more variable than previously reported.
When investigating the nucleotide databases for CPEB3 isoforms, we were able to
identify eight transcript variants (figure 28, isoform 1a-1 d, 3-6). When a similar search
was performed for the protein databases, we were able to identify seven distinct CPEB3
protein isoforms (figure 29). With the aid of sequence alignment tools, we mapped the
126

Figure 27. Multiple unique motifs of CPEB3 protein
Multiple unique motifs are present in CPEB3 protein, as demonstrated by sequence
alignment of CPEB2, CPEB3, and CPEB4 proteins. A glutamine rich motif (poly-Q track),
a 23-amino-acid fragment, and an 8-amino-acid fragment (highlighted in blue) are only
present in CPEB3. Sequences highlighted in yellow are two RNA recognition motifs that
are highly conserved among CPEB2-4.

The phosphorylation site of CPEB3 is also

indicated in yellow, which seems to be homologous in CPEB4.

For simplicity, only

Ref Seq sequences are used for the alignment. Accession numbers are as following:
NP_787951.1 for CPEB2, NP_938042.2 for CPEB3, and NP_080528.2 for CPEB4.
Asterisk indicates 100% conservation; colon indicates substitution with a similar amino
acid; period indicates substitution with a distinct amino acid.
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cDNAs to genomic DNA and identified multiple alternatively spliced regions. We also
inferred the matches of cDNAs variants to protein isoforms (figure 28, 29).
Besides the two previously reported sequences whose deletion results in isoforms 2, 3,
and 4, several other alternative splicing regions were found to be present. One location
was near exon 11. The prototypical isoforms have exon 12 immediately following exon
11 (figure 28, isoform 1a-1 d, 2, 3, 4, and 6). However, the isoform 5 has an extended
exon 11 (by "bleeding into intron 11"), which causes a completely different 3' UTR and
the omission of exon 12 (figure 28). Consequentially, the derivative protein terminates
with four unique amino acids (VELA) and is deprived of the second RNA binding motif
and the zinc finger domain (figure 29, isoform 5).
Another variable region is within exon 4. Two deletion variants can occur within this
exon. One deletion leads to the use of an alternative starting codon, resulting in the
removal of the first 216 amino acids in the derived protein (figure 28 and 9, isoform 6).
The other deletion variant, for which the cDNA could not be identified in the UniGene
nucleotide database, has a derived protein with a deletion of 83 amino acids, ending with
the 197th serine (figure 29, isoform 7). The 197th serine can be essential for the function
of CPEB3, since it has been recently shown to be the phosphorylation site of CPEB3
when synaptosomes were stimulated with KCI (Munton et al. 2007).
In addition to these splices which lead to altered protein sequences, there are other
splices in the cDNAs which do not demonstrate differences in protein sequence, but
rather show variance in their UTR regulatory regions. For example, alternative usage of
exon1, 2, and 3 results in different 5' UTRs (figure 28, isoform 1a, 1b, 1c); alternative
usage of poly(A) Signals in exon 13 leads to different 3' UTRs (figure 28, isoform 1d).
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Figure 28. Analysis of CPEB3 transcript variants in the database
Nine different transcripts of CPEB3 have been reported to the UniGene database or in
research paper.
Upper Panel: Representation of genomic sequence with boxes representing exons and
lines representing introns. Lower Panel: The cDNAs derived from alternative splicing.
Nine cDNAs were shown here, with their accession numbers and types of tissue (when
available) given to the right. Partial sequence of isoform 2 (exon 5-7) was confirmed
with PCR in a previous study (Theis et al. 2003), but we were unable to identify the
accession number in the database, thus its complete sequence shown here was
uncertain. The first four isoforms are named as 1a-1 d in our study because they code
for the same protein. The difference between these four sequences solely reside in
untranslated regions. The translational start codons and stop codons were annotated on
top of the genomic DNA. The alternative splices of coding exons 4, 5, 7 and 11 generate
different proteins presented in figure 29. Alternative splices upstream of the translational
start locations (exon 1-3) or downstream of the stop locations (exon 13) give rise to
different 5' UTR and 3' UTRs, respectively.
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Figure 29. Analysis of CPEB3 protein isoforms in the database
Seven isoforms of CPEB3 proteins have been documented in the database.
Isoforms 1-6 corresponded to the same numbered cDNA transcripts in figure 28. Protein
isoform 1 was derived from the cDNA variants 1a-1 d. The cDNA sequence for protein
isoform 7 could not be identified in the database. For simplicity, Poly-Q (poly-glutamine),
SA (Ser-Ala track), 23 a.a. and 8 a.a. motifs are only labeled in isoform 1.

Colored

boxes represent possible functional motifs. Boxes in dash-lines represent deletions.
197 P represents the 19ih serine phosphorylation site for CPEB3. RRM represents RNArecognition motif. The position of the colored-box motifs and dash-line-box motifs are
indicated at the top and the bottom. The length, the molecular weight and the accession
number of each isoform are indicated to the right (Swiss-ProtlTrEMBL number is unbracketed, NCBI number bracketed).
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3) Multiple isoforms of CPEB3, including a novel isoform, were experimentally
identified in the mouse retina. These isoforms have a wide tissue distribution;
and only the (+69+24) variant is selectively expressed among different tissues.

Apart from the presence of CPEB1 in the retina, we investigated whether CPEB3 mRNA
is present within the mouse retina. The CPEB3 primer set was designed to flank multiple
exons to exclude the genomic DNA, with no significant homology to any other genes.
RT-PCR results demonstrated that CPEB3 is expressed in the retina (figure 30a). [3actin primers were used in both positive and negative controls. The negative control
contained all necessary components except that reverse transcriptase was omitted for
the RT step. Should there be any contamination from the reverse transcription
components, the PCR components, or during the setup of either experiment, it would be
amplified in the negative lane. The lack of bands in this lane confirmed that the signals
in the other lanes are specific.

Next, we investigated whether CPEB3 transcript variants identified through the
bioinformatics analyses were present in the mouse retina. Total RNA isolated from P60
mice retinas and primer sets designed spanning exon 5-7 or exon 11 (figure 30d) were
used for RT-PCR. Amplicons of the PCR reactions were separated on agarose gel, and
individual bands were extracted and sequenced to confirm their identity. Since partial
sequences instead of complete sequences were amplified here, one amplicon may
correspond to more than one of the transcripts (figure 28). Therefore, in this section, we
used descriptional names instead of numerical isoform names for each amplicon.
"+69+24" (corresponding to figure 28, isoform 1a-1 d), "-69+24" (figure 28, isoform 3, 5,
and 6), "+69-24" (figure 28, isoform 2), and "-69-24" (figure 28, isoform 4) were used to
designate each variant in the exon 5-7 region; and "extended exon 11" (figure 28,
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Figure 30. Tissue distribution of CPEB3 transcript variants
a) CPEB3 is present in the P60 retina. Both the primers in CPEB3 and

~-actin

span

multiple exons to discriminate genomic DNA.
b) RNA from adult retina was reverse transcribed and different primer sets for
various CPEB3 isoforms (sequences listed in table1) were used for PCR. Each
visible band was purified and sequenced to confirm its identity. This data
demonstrated the presence of five variants: "+69nt+24nt" (lane2, upper band), "69nt+24nt" (lane2, lower band), "exon11 +intron11 bleeding" (lane3),
"exon11+exon12" (lane 4, upper band); and a new isoform: "-exon11" (lane 4,
lower band). But it does not rule out the presence of "+69-24" and "-69-24", since
the competition for the same set of primers by a more dominant variant ("-69+24")
may mask the weakly expressed variants.
c) Demonstration of "+69-24" and "-69-24" transcripts and comparison of tissue
distribution of all variants. Unique primer sets for each individual variant were
used for PCR on thirteen different adult mouse tissues. Each specific band was
cut out and sequenced for confirmation. The results demonstrated the presence
of "+69-24" and "-69-24" variants in the retina (in supplement to figure b). It also
demonstrated the ubiquity of the majority of the variants, with the exception of
"+69+24" which was expressed in the central nervous system, the ovary, testis,
kidney and heart but.absent in the lung, liver, thymus and spleen. Negative
controls indicated no contamination from either the RT or the PCR reactions.
d) Mapping of the location of primers used in b) and c) to the CPEB3 cDNA. The
sequences of these primers were listed in table 4. CPEB3 isoforms
corresponding to each variant were listed to the right.
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isoform 5), or "exon 11+exon 12" (figure 28, isoform 1a-1d, 2, 3, 4, and 6) for variants
near the exon 11 region.

Our results from RT-PCR demonstrated the presence of "+69+24", "-69+24" (figure 30b,
lane2) in exon 5-7 region; "extended exon 11" (figure 30b, lane3), and "exon 11+ exon
12" (figure 30b, lane4 upper band) around exon 11 region in the retina. Additionally, a
novel CPEB3 isoform without exon 11 ("-exon 11 "), confirmed by sequencing, was also
identified in the retina (figure 30b, lane 4 lower band). This is the first time this isoform
has been shown.

For the exon 5-7 region, although only two bands were detected in the RT-PCR, it was
possible that more dominant transcripts "masked" weaker transcripts by competition for
the same set of primers. Therefore, we designed separate sets of primers for individual
transcripts in this region to further explore their presence or absence (figure 30d). Each
specific band was cut out and sequenced for confirmation (data not shown). Our results
demonstrated that the "+69-24" and "-69-24" variants were indeed present in the retina
(figure 30c).

We also collected multiple tissues to test all known transcripts for possible tissue
specificity.

Of all the variants tested, the majority did not appear to differ with respect to

tissue distribution. The only exception was the "+69+24" variant, which was strongly
expressed in the central nervous system, ovary, testis, kidney and heart, but not in the
thymus, spleen, lung or liver (figure 30c).
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4) Localization of CPEB3 mRNA within the retina: the CPEB3 transcripts are
expressed predominantly in the retinal ganglion cell layer
With the aid of In situ hybridization, we identified which types of cells in the retina
express CPEB3 mRNA in the P60 mouse. To ensure specificity, probes were designed
in a region where little homology was found between CPEB3 and the other CPEBs. A
sense probe at the exact location was used as a negative control. The primers used to
generate the sense and antisense probes were listed in table 3. Our results
demonstrated that CPEB3 is localized predominantly in the RGC layer, and to a less
extent, in the inner margin of the INL (figure 31). CPEB3 appeared to be present in the
plexiform layers as well, but no synaptic structure was identifiable due to the limitation on
the resolution of in situ hybridization technique.

5) CPEB3 transcription is up-regulated during postnatal development of the retina

To investigate the expression of CPEB3 during development, real-time PCR was used to
evaluate the relative amount of CPEB3 mRNA in the retinas of mice at different ages. An
amplicon of 79 nt spanning exon 4 and exon 5 was amplified, and was inclusive of all
CPEB3 isoforms (table 8).

Our results (figure 32) demonstrated that the overall

transcription level of CPEB3 was up-regulated thoughout postnatal development in the
retina. A significant increase in the level of CPEB3 transcripts was seen around the eye
opening time (P14).

The level of CPEB3 transcripts continued to increase after eye

opening, and until adulthood (P60).

Since the CPEB3 primer set for real-time PCR

matched all known CPEB3 isoforms, the data did not distinguish each transcript variant.
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Figure 31. Localization of CPEB3 mRNA in the retina

14um thick cryostat sections of P60 mouse retina were used for in situ hybridization of
CPEB3. The probes were designed in a region with no significant homology to the other
three CPEBs to ensure probe specificity.

The expression of CPEB3 mRNA was

predominantly located in the RGC layer and to a lesser extent, the INL.

The IPL

appeared to be labeled as well, but the synaptic structures could not be recognized due
to the limitation on the resolution of in situ hybridization techniques.
represented 50 11m.

Scale bar

ONL: outer nuclear layer; OPL: outer plexiform layer; INL inner

nuclear layer; IPL: inner plexiform layer; RGC: retinal ganglion cell layer.
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Figure 32. Developmental pattern of CPEB3 mRNAs
CPEB3 mRNA was up-regulated during postnatal development. Seven post natal ages
flanking the eye-opening event were used for this study. For each sample the level of
CPEB3 mRNA was normalized to that of 18S mRNA in the exact same sample. The
relative fold changes were acquired by calibrating the older ages to age. All experiments
were repeated three times. Statistically significant differences were indicated between
two bracketed ages (p<=0.05). The Anova procedure Tukey's Studentized Range (HSD)
was used. For each age, the number of samples n>=6. Error bars represented the
standard deviation. The asterisk indicated the approximate time of eye-opening. The

results demonstrated that CPEB3 was significantly up-regulated in the retina during
postnatal development and reached its maximum in adult mice (day 60).
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Figure 32

CPEB3 transcription is upregulated in the developing retina
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P60

6) Localization of CPEB3 protein: CPEB3 protein is predominantly expressed in the
inner retina

To confirm the expression pattern of CPEB3 mRNA and to better define the cell types
containing CPEB3 protein, we performed fluorescence immunocytochemistry using an
antibody to CPEB3 (figure 33, 34). A similar pattern was observed as for the in situ
hybridization: CPEB3 protein was predominantly expressed in the retinal ganglion cell
layer, and to a less extent, within the inner boundary of the INL (figure 8). To define the
type of cells which express CPEB3 we used double immunolabeling with cell-type
specific markers, specifically, ganglion cell specific marker MAP1 a (Tucker and Matus
1988; Okabe et al. 1989), or cholinergic amacrine cell marker ChAT (Eckenstein and
Thoenen 1982; Tumosa et al. 1984; Schmidt et al. 1985; Pourcho and Osman 1986;
Tumosa and Stell 1986; Voigt 1986), in combination with CPEB3.

Confocal images

indicate that most CPEB3-postive celis in RGC layer are ganglion cells (figure 33), and a
few are displaced amacrine cells (figure 34).

Both the inner plexiform layer and outer plexiform layer appeared to be immunopositive
for CPEB3 labeling (figure 33, 34).

The pattern of CPEB3 in the IPL was diffuse

compared to the more laminar pattern of CPEB1 in the same layer (figure 22, 23).
Within the location of immunogen for CPEB1 antibody (167-184 a.a.) and that of CPEB3
antibody (between 300-400 a.a.), little homology between CPEB1 and CPEB3 was
found. Therefore, cross-reactivity between the two antibodies seemed highly unlikely.
The identity of synaptic structures in the plexiform layers was not determined. An
extensive characterization with double and triple labeling methods was beyond the
scope of this dissertation.
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Figure 33. Localization of CPEB3 protein- with MAP1 a

Double-immunofluroscence of CPEB3 and MAP1 a on P60 mouse retina indicated that
the majority of CPEB3 positive celis in the retinal ganglion celi (RGC) layer were also
MAP1a positive. MAP1a has been demonstrated as a marker for retinal ganglion celis.
The absence of labeling when CPEB3 antibody was pre-adsorbed with recombinant
CPEB3 protein (right upper panel) demonstrated the specificity of the CPEB3 antibody.
Images were acquired with the aid of an Olympus confocal microscope. The scale bar
represented 50 um.
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Figure 34. Localization of CPEB3 protein- with ChAT
Double-immunofluorescence of CPEB3 and ChAT on p60 mouse retina indicated that a
few CPEB3 positive cells in RGC layer were also ChAT positive, as indicated with the
arrows. ChAT is a marker for cholinergic amacrine cells and displaced amacrine cells.
This suggested that a few CPEB3 positive cells in RGC layer were displaced amacrine
cells. The size of such cells was usually smaller than those staining positive for both
CPEB3 and Map1 a in the RGC layer. Scale bar represented SOum.
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Figure 34
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7) Developmental regulation of CPEB3 protein: CPEB3 protein is up-regulated
during postnatal development of the retina

Our next aim was to investigate the relative abundance of CPEB3 protein in the
developing retina with the aid of Western blots. To examine antibody specificity we used
a recombinant CPEB3 protein to pre-adsorb the antibody. This served as a negative
control. The GST-CPEB3 fusion protein induced in E. coli was visualized on SDS-PAGE
gel (figure 35a). The induced protein was then purified by immunoprecipitation, and
subjected to mass spectrometry for identification. MS results (figure 35b) confirmed its
identity as CPEB3.

The fusion protein was then used as a blocking reagent for the

CPEB3 antibody.

We identified four immunopositive bands in Western blots that were diminished by preadsorption (figure 35c). These included bands with relative molecular weight of -130kD,
75kD, 67kD and 62kD. The 75kD band appeared to be the mature form based on its
predicted size in the database. Our results indicated that this band increased
significantly in intensity during postnatal development of the retina. This was consistent
with data demonstrating a postnatal increase in CPEB3 mRNA (figure 32). The other
bands may represent isoforms from other transcript variants present in the retina,
breakdown products, or other CPEB3-related products. One band (-11 Ok D) appeared
not to be blocked by the pre-adsorption of antibody with fusion protein. The unblocked
band may be a problem when the same antibody was used for immunohistochemistry;
however this issue was resolved by using pre-adsorbed antibody as a negative control
for the immunocytochemistry, which showed no signal. Statistical analysis (ANNOVA T
tests) indicated that there was significant increase in the level of CPEB3 (75kD) from P1
and P7 to P12 (figure 35d).
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Figure 35. Developmental pattern of CPEB3 proteins

CPEB3 protein was up-regulated during the postnatal development of the retina.

a) The expression of recombinant CPEB3 protein. An extra band of the expected
size for GST-CPEB3 fusion protein appeared in IPTG- induced sample (+)
compared to non-induced sample (-).
b) The extra band in samples induced for recombinant CPEB3 was cut out and
subjected to mass spectrometry. The pattern from MS confirmed that this band
was recombinant CPEB3 protein.
c) CPEB3 western blot on retinal samples from mice of different postnatal ages.
The results showed that there was an increase in the amount of CPEB3 protein
during the development (75kD band). This band disappeared when the antibody
was pre-adsorbed with the recombinant CPEB3 antibody (the two lanes to the
right). Another two bands at -130kD and -65kD respectively also disappeared
when CPEB3 antibody was pre-adsorbed with recombinant CPEB3 proteins,
suggesting that they represent different forms of CPEB3. The up-regulation of
CPEB3 protein during development is consistent with that of CPEB3 mRNA.
GAPDH was used as a loading control.
d) Quantification of the level of CPEB3 protein during development. Significance
up-regulation was observed between two bracketed age set: P1 to P12, and P7
to P12 (p<=O.05). Each CPEB3 band was normalized to the GAPDH band in the
same sample. Annova was used for statistics on three biological repeats. Error
bars indicated standard deviation.
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In summary, our study identified several CPEB3 isoforms (both mRNA and protein) from
the NCBI and Swiss-ProtlTrEMBL databases. A novel CPEB3 isoform was identified
experimentally for the first time. Among the previously known isoforms and the isoforms
we identified, only one had discriminative tissue distribution. Our data also
demonstrated the presence of CPEB3 in the retina. CPEB3 was predominantly
expressed in the inner retina. Both the mRNA and the protein levels of CPEB3 were upregulated in the retina during postnatal development.

3. CPEB1-4 comparisons
Four CPEB paralogs, CPEB1-4, have been identified in rodent. Current studies on
cytoplasmic polyadenylation are predominantly focused on CPEB1, whereas the
mechanisms of CPEB1 are yet to be fully established. Very little is known with regard to
CPEB2-4. We were able to draw some comparison among the four CPEBs based on
our study within the retina.

1) Sequence comparison of CPEB1-4
Some comparisons have been made among CPEB1-4 in the literature with regard to the
RNA recognition domain (Theis et aI2003). In our study we performed a comprehensive
sequence alignment of those four.

Since CPEB1 is more distant to CPEB2-4 in the

family tree, therefore, we first aligned CPEB1-4 (figure 36). Then, in order to better
reveal the differences and similarities between CPEB2-4, we aligned these three
separately (figure 37).
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Figure 36. Sequence alignment of CPEB1-4 proteins
Sequence alignment was performed using ClustalW. Sequences with the following
accession numbers were used: CPEB1: NP_031781.1; CPEB2: NP_787951.1; CPEB4:
NP_938042.2; CPEB4: NP_080528.2. The alignment demonstrated higher homology in
the C-terminus compared to the N-terminus. CPEB1 had more variance from CPEB2-4
across the whole sequence. Asterisk represented 100% identity; colons represented
substitution with a similar amino acid; period represents substitution with a different
amino acid.
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Figure 36 (to be continued)
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Figure 36 (continued)
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Figure 37. Sequence alignment of CPEB2-4 proteins
Sequence alignment was performed using ClustalW. Ref Seq sequences with the
following accession numbers were used: NP _787951.1 for CPEB2, NP_938042.2 for
CPEB3, and NP_080528.2 for CPEB4. Sequences highlighted in blue were unique to
CPEB3, and sequences highlighted in yellow were highly conserved among CPEB2-4.
Asterisk indicated 100% conservation; colon indicated substitution with a similar amino
acid; period indicated substitution with a distinct amino acid.
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The comparison clearly demonstrated that the N terminus is more diverse among the
different paralogs. The C-terminus, where the important functional domain such as
RNA-recognition motifs reside, is highly conserved. The C-terminus is almost identical
for CPEB2-4 (95% identity according to figure 10); however, it varies significantly from
the terminus of CPEB1 (45% identity according to figure 10).

2) All four CPEBs are present in the retina
With the aid of regular RT-PCR, we explored the presence of four CPEB paralogs in the
retina (figure 38). Total retinal RNA from adult mice was used for the amplification. The
primer set for each gene was designed to be exclusive of each other. Amplicons were
separated on agarose gel. Distinct bands were cut out and sequenced to confirm the
identity. The result demonstrated the all four CPEB mRNA are expressed in the retina.
Due to possible differences in amplification efficiency of each primer set, this data is not
suitable for quantitative studies, which will be obtained later using real-time PCR
experiments (see below).

3) Cellular localization of CPEB1-4 mRNA
With the aid of in situ hybridization, we compared the tissue distribution of four CPEBs in
the retina (figure 39). Each probe was specifically designed with no significant similarity
to others. The sequences of the template for each probe were confirmed with
sequencing analysis. In situ hybridization demonstrated a similar pattern of four CPEBs:
predominantly expressed in the retinal ganglion cell layer; to some extent, to the inner
layers of the inner nuclear layer. Some signal appeared to be in the inner plexiform
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Figure 38. Presence of four CPEBs in the retina
P60 mouse retinal total RNA was used for the RT-PCR. l3-actin was used as a positive
control. The "-" control had all the components as l3-actin reaction except that the
reverse transcriptase was omitted at the RT step. The primer sets for all genes were
designed with low homology with each other or with any other genes. Each band in the
agarose gel was cut out, purified and sequenced to confirm its identity. The results
showed that all four CPEB homologs were expressed in the retina. This result was not
suitable for quantification, since each set of primers may have distinct amplification
efficiency. Quantification analysis would be inferred from real-time PCR data in later
sections.

158

Figure 38
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Figure 39. Localization of four CPEB mRNAs in the retina
P60 slides were used for in situ hybridization. Probes for each gene were designed
within a region that was less homologous to the other homologs or any other genes.
The sequences of all probes were confirmed via sequencing. The results demonstrated
that CPEB 1-4 have a similar pattern of distribution within the cellular layers of the retina:
predominantly in RGC layer, to some extent, in the inner layers of INL. Their distribution
in synaptic structures in the plexiform layers could not be confirmed at this point due to
the limitation of the resolution of this technique. This result was not suitable for
quantification analysis due to the fact that different probes may have distinct binding
efficiencies to their complementary mRNA. Quantitative studies would be done based
on real-time PCR data.
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Figure 39

CPEB2

CPEB3

CPEB4
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layers, although the fine synaptic structures were not distinguishable due to the
resolution of this technique. This data is not suitable for quantitative comparisons since
different probes may have different efficiencies for hybridization. Quantitative analysis
will be done based on real-time PCR data.

4) Developmental regulation of CPEB1-4
The expression pattern of each CPEB during the development was explored using realtime PCR methods. Total retinal RNA from each age was used in combination with
gene-specific primer sets and gene-specific FAM-Iabeled probes. The level of each
gene was normalized to the level of 188 in the same sample. Relative fold changes
were acquired by calibrating transcript levels of each age to the age of P1. Different
developmental expression patterns were revealed for the four genes (figure 40): For
CPEB1 and CPEB3, significant up-regulations were observed throughout development.
Both increases started early in development and continued until adulthood. CPEB4 was
mildly up-regulated during development; while CPEB2 stayed rather constant throughout
development.
For CPEB1 and CPEB3, the mRNA in P12 was increased significantly compared to P1
or P7. The level of mRNAs between P12, P14 and P16 was more like a plateau, with no
significant increase between those three ages. Another significant increase occurred in
P30, compared to P14 or P16 for CPEB1 and CPEB3, respectively. For CPEB4, a
significant increase was found in P12 compared to P1; no significant changes were
found between P12, P14 and P16; the level of CPEB4 was increased significantly further
in adult (P60) compared to P12. The overall increases in the level of transcripts of
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Figure 40. Four CPEBs - trends in development

Total RNA from the retinas of postnatal day1, 7,12,14,16,30, and 60 mice which were collected at the same time of the day was
used for real-time PCR assays. The combination of gene-specific primers and FAM-Iabeled gene-specific probes ensured high
specificity. 18S was used as an endogenous control. The relative fold changes were acquired by calibrating all the older ages to
age P 1. Each age had 6-10 animals. The Anova procedure, Tukey's Studentized Range (HSO) was used for statistics. Error bars
indicated standard deviation (SO). Significant changes were demonstrated between each two bracketed ages (p<=0.05). The results
demonstrated significant increases of CPEB1 and CPEB3 mRNA during post-natal development. CPEB4 had a slow increase; while
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CPEB 1, CPEB3, and CPEB4 from the newborns to the adults were 6-fold, 13-fold, and
2.5-fold respectively.

5) Relative abundance of four CPEBs
Comparisons across genes were derived from the real-time PCR data. Relative levels of
mRNA for different genes were acquired by simply normalizing levels of each gene to
that of 18S in the same sample. Strikingly, the most abundant gene among four CPEBs
was not the overtly regulated ones.

The most abundant gene among all four was

CPEB4. The level of CPEB3 was the second most abundant. Both CPEB3 and CPEB4
were more than one magnitude, sometimes two magnitudes more abundant than
CPEB1 and CPEB2. CPEB1 was less abundant than CPEB2 in the early ages, but then
surpassed CPEB2 as it was up-regulated in the later ages (figure 41). The level of
CPEB2 was consistently low.

In summary, our data demonstrated that all four CPEBs were expressed in the retina.
The mRNAs of all four CPEBs were predominantly localized in the retinal ganglion cell
layer.

The transcription of CPEB1, 3 and 4 was up-regulated during postnatal

development; while CPEB2 stayed rather constant. The relative abundance at any given
age was CPEB4 > CPEB3 > CPEB2 or CPEB1. In early ages (P1 and P7), CPEB2 was
more abundant than CPEB1, in older ages (P30 and P60), CPEB1 surpassed CPEB2.
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Figure 41. Comparison of the relative abundance of four CPEBs

Total RNA from the retinas of postnatal day1, 7, 12, 14, 16, 30, and 60 mice which were collected at the same time of the day was
used for real-time PCR assays. The combination of gene-specific primers and FAM-Iabeled gene-specific probes ensured high
specificity. 18S was used as an endogenous control. The relative fold changes were acquired by calibrating all the older ages to
age P1. Each age had 6-10 animals. The Anova procedure, Turkey's Studentized Range (HSO) was used for statistics. Error bars
indicated standard deviation (SO). Significant differences were indicated between each two bracketed ages (p<=0.05). The results
demonstrated that of any given age, CPEB4 mRNA was the most abundant; CPEB3 was the second most abundant. CPEB1 mRNA
...... was the lowest, but because of its up-regulation during the development, it surpassed CPEB2, which stayed constant, in older
0)
0)

animals.
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CHAPTER V
CONCLUSIONS AND DISCUSSION

In conclusion, these studies demonstrate that all four CPEBs are present in the mouse
retina. The spatial distribution patterns of the transcripts of four CPEBs are somewhat
different but all four are predominantly localized in cells of the inner retina. The temporal
expression patterns, in particular are quite different for the four CPEBs. Thus, CPEB1
and CPEB3 are up-regulated in the retina during development and reach a maximum in
adulthood; CPEB4 is up-regulated to a lesser extent throughout this period; while
CPEB2 stays rather constant. These different spatio-temporal patterns may reflect their
as yet undiscovered roles in the retina.

In this study we also screened for potential mRNA targets of CPEB1, using a
combination of computational programming and wet-lab experiments. Some of these
mRNAs acquired elongated poly(A) tails during the earliest periods of postnatal
development.

In addition, multiple CPEB3 transcript variants and CPEB3 protein

isoforms were identified from an analysis of the national databases (NCBI, SwissProtfTrEMBL).
distribution.

One of these isoforms was found to have a discriminative tissue

Additionally,

a novel transcript of CPEB3 was identified through these

studies. This new isoform which lacks exon11 is present in all tissues tested including
the retina.
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DISCUSSION

1. Distinct expression patterns and sequence discrepancies indicate functional
divergences between members of the CPEB family

The expression patterns of four CPEBs in the retina demonstrated some uniqueness for
each paralog. Although in situ hybridization data showed similar patterns of the four,
localization data from immunohistochemistry microscopy refined the differences between
the patterns of CPEB1 and CPEB3 in the inner plexiform layer. CPEB1 had a laminar
structure, while CPEB3 was more diffusive. Developmental studies further compared
the regulation of four CPEBs postnatally. From newborn to adult, CPEB1 and CPEB3
was up-regulated 6-13 fold, respectively; CPEB4 increased by about 1.5 fold, whereas
CPEB2 stayed constant. Both the spatial and temporal patterns of CPEBs in the retina
revealed some degree of diversity. Similarly, distinct expression patterns of CPEB1-4
were also reported in the hippocampus (Theis et al. 2003; Huang et al. 2006).

Sequence comparisons demonstrated that CPEB1 is distant from CPEB2, 3 and 4. The
highly conservative C- terminus of CPEB1 had merely 45% identity to the other three.
The RNA recognition motifs between CPEB2, 4 and the prototypical CPEB3 are 97-99%
identical, indicating high degree of overlapping with respect to substrate specificity.
However, their N-termini where regulational domains such as phosphorylation sites
reside are dramatically variable.

The accumulative evidence on the structure, distribution, and regulation of CPEBs may
dictate their functional distinctness. Such differences may embody multiple aspects
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such as spatial and temporal availability, substrate specificity, responses to discrete
stimuli, and signaling cascades they are associated with.

With those notions made, four CPEBs share some common features both structurally
and functionally. Current knowledge on CPEB1, which has been studied most
extensively, may be applicable to speculate on CPEB2-4 when appropriate to broaden
our view.

2. CPEBs and the inner retina

1) CPEBs are expressed in the RGC layer, the INL, and the IPL.
All four CPEBs are present in the inner retina. In situ hybridization indicated that
transcripts of all four CPEBs are predominantly expressed in the retinal ganglion cell
layer, and to some extent, in the inner nuclear layer. Immunocytochemistry with
available antibodies to CPEB1 and CPEB3 showed positive lableling in retinal ganglion
cells and amacrine cells. Only a subset of ganglion cells are positive for CPEB1 or
CPEB3, since not all MAP1 positive cells are CPEB1 positive or CPEB3 positive.
Similarly, only a small population of cholinergic amacrine cells is CPEB3 or CPEB1
positive.
Immunofluorescence labeling of fixed tissue sections also strongly demonstrated the
presence of CPEB1 and CPEB3 within the inner plexiform layer. CPEB1 labeling was
associated with laminar structures in the inner plexiform layer, whereas CPEB3 labeling
demonstrated a more diffuse pattern. The CPEB1 immunopositive laminae did not
appear to co-localize with ChAT immunolabeling. The close juxtaposition of the CPEB1
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positive laminae to ChAT positive laminae suggested that CPEB1 laminae may reside in
sublamina a and sublamina b of the IPL.

2) The identities of the CPEB positive cells and/or synapses need to be further
characterized.
The subtypes of the CPEB1 or CPEB3 positive ganglion cells were not specifically
identified in our study but should be pursued in future studies. About 11 morphologically
distinct subtypes of RGCs with distinct dendritic architectures are known to be present in
the mammalian retina (Cajal 1893; Yamagata and Sanes 1995a; Yamagata and Sanes
1995b; Rodieck 1998; Rockhill et al. 2002). More than a dozen of subtypes of amacrine
cells have been described (Kolb 1997) based on the diameter of their dendritic field and
the sublamina where their synapses are located. The number of types of amacrine cells
continues to grow as techniques such as intracellular physiological recording,
immunohistochemistry, and biochemical methods became available (Casini et al. 1995;
Crooks and Kolb 1992; Kolb et al. 1992; MacNeil and Masland 1998).
Immunohistochemistry combining CPEB antibody with the subtype-specific antibodies
can help to pinpoint the identity of the CPEB positive cells.
Similarly, the identity of the CPEB positive structures in the inner plexiform layer can be
addressed. The IPL was divided into five equal-thick strata (CajaI1892) into which
synapses between bipolar, amacrine and ganglion cells can be assigned. A sublaminar
division was later applied to the IPL in superimposition to Cajal's five strata (Famiglietti
and Kolb 1976): sublamina a corresponds to strata 1-2; sublamina b corresponds to
strata 3-5. Distinct subtypes of RGCs maintain their functional specificity by forming
synaptic connections with appropriate pre-synaptic bipolar cells or amacrine cells at
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distinct sublaminae of the IPL. Many amacrine cells make their contacts with RGCs in a
single stratum in the IPL, but some are bi-stratified or even tri-stratified (Strettoi et al.
1992; Zucker and Ehinger 1998; Loeliger and Rees 2005; Mojumder et al. 2008).
Further characterization need to be done to identify CPEB structures in the IPL with the
assistance of cell-type specific markers.

3) The laminar structure of CPEB1 labeling in IPL may be related to ON and OFF
pathways
One of the basic principles of the visual signal processing in the visual system is the
separation of ON and OFF pathways at virtually all levels of the visual pathway. The ON
pathway responds to onset of a light stimulus; while the OFF pathway to the termination
of a light stimulus. The separation of ON pathway and OFF pathway starts at the first
synaptic contact - the bipolar cell level in cone-driven systems, and at the second
synaptic contact - amacrine cell level in rod-driven system. They remain separated at
the retinal ganglion cell level, and in upper levels of the visual system such as the lateral
geniculate nucleus (LGN) and the visual cortex. Cone ON-bipolar cells are thought to
exclusively express metabotropic glutamate receptor 6 (mGluR6), and form synaptic
contacts with ON ganglion cells in sublamina b of the IPL; whereas OFF bipolar cells
form synaptic contacts with OFF ganglion cells in sublamina a.
At least two laminar structures in the IPL for CPEB1 labeling were distinguishable. They
appeared to be non-cholinergic synapses since they did not co-localize with ChAT
labeling. But they appeared to be in close proximity of the two ChAT positive laminar
structures, which are known to reside at strata 2 (within sublamina a) and strata 4 (within
sublamina b) respectively (Kang et al. 2004). It is highly likely that the two CPEB1
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positive lamina structures are located in sublaminar a and sublamina b, respectively,
which will make a plausible inference that CPEB1 in these two synaptic bands contribute
to OFF pathway and ON pathway.

4) The spatial patterns of CPEBs resemble that of some synaptic molecules which
are potential targets of CPEBs
Although the significance of the distribution pattern of CPEBs in the retina is yet to be
delineated, we realized that such expression patterns resemble the known expression
patterns of some synaptic molecules which are potentially targets of CPEB based on our
investigation. Such mRNAs include: CaMKIl (Liu et al. 2000), NR1, NR2A-D (Grunder et
al. 2000b; Araki and Hamassaki-Britto 2000), GluR1, and GluR2 (Grunder et al. 2000a;
Hack et al. 2001; Kamphuis et al. 2003; Dijk and Kamphuis 2004).
Immunohistochemistry in combination with in situ hybridization can determine whether
these mRNAs co-localize with CPEBs in the retina. This may help to clarify the
relationships between these molecules and CPEB.

3. CPEB3 and the outer retina
One of the differences between the spatial patterns of CPEB3 and CPEB1 was that
CPEB3 was present in the outer plexiform layer at a more profound level (figure 22, 23,
33, 34). This may indicate a distinct aspect of the function of CPEB3 in the outer
plexiform layer. Although we did not determine whether CPEB3 is localized in the presynaptic or post-synaptic compartment due to the lack of a good post-synaptic marker
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(Aartsen et al. 2006), further investigation on the subcellular location of CPEB3 is
necessary for delineating its role in outer plexiform layer.
The outer plexiform layer possesses some degree of plasticity for structural and
functional remodeling. Ectopic synaptogenesis was observed in retinas undergoing
degeneration. For instance, the retina with mutations for presynaptic cytomatrix protein
Bsn, calcium binding protein Cabp4, or the calcium channel protein, Cacna1f,
manifested impaired synaptic transmission. Along with the structural and functional
defects, horizontal cells and bipolar cells grew their neurites into the outer nuclear layer,
an area usually devoid of synapses, and formed synaptic contacts with the
photoreceptor cells (Chang et al. 2006; Mansergh et al. 2005; Dick et al. 2003;
Haeseleer et al. 2004). Such ectopic synapses were formed de novo, long lasting and
capable of sustained neurotransmitter release (Specht et al. 2007). Similar remodeling
in the outer plexiform layer has been reported in other types of genetically modified mice
with photoreceptor degeneration (Peng et al. 2000; Strettoi and Pignatelli 2000; Claes et
al. 2004; Strettoi et al. 2004; Jansen and Sanyal 1992; Peng et al. 2003). It was also
observed under pharmacological conditions (Wang et al. 2008) or pathological
conditions such as stroke, AMD or normal aging retina (Eliasieh et al. 2007; Sullivan et
al. 2007).
The mechanism underling such synaptic plasticity is yet to be unraveled. It is not known
whether the retina recapitulates the mechanism from other parts of the CNS, such as the
hippocampus and the visual cortex, where CPEB mediated local translation plays a key
role in the LTP or LTD. One possible theory is that CPEB3 expressed in the outer
plexiform layer is involved in processes related to synaptic activity. Mutant or
pathological models can be used to determine whether there is an association of CPEB3
with synaptic remodeling in the outer plexiform layer in the retina.
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4. CPEB1, CPEB3, CPEB4 and synaptogenesis
Three CPEBs, CPEB1, 3, and 4 were up-regulated during the postnatal development of
the retina. The significant increases occur between P1 and P12, as well as between
P16 to P60. The increases of these three CPEBs were less profound around eyeopening time (P12 to P16). The enhanced expression of these genes during
development, both at transcriptional level and translational level, may be a good
indicator for their possible involvement in synaptogenesis.
It is well established that the mammalian retina is premature at birth. Mouse retina
reportedly matures on postnatal day 41 (Blanks and Bok 1977). The ganglion cell layer
and the inner plexiform layer are recognizable at the time of birth, but the remainder of
the retina is yet to be fully developed. The synaptogenesis in the inner plexiform layer
(IPL) starts at day 3 and slows down precipitously at day 15 (around the time of eyeopening (Fisher 1979b; Fisher 1979a). Robust glutamatergic synaptic formation occurs
in the second postanatal week, and synaptic sublamina in the inner plexiform layer
becomes visible on day 12 (Sherry et al. 2003). Synaptic connections in OPL begin to
develop on day 3 and are well established by day 12, the time when the first light
response was recordable as ERG (Rich et al. 1997). Synaptic contacts between
photoreceptors and bipolar cells in the OPL, and between bipolar cells and ganglion
cells in the IPL are established slightly before eye opening (Marquardt and Gruss 2002).

The up-regulation of CPEB 1, CPEB3, and CPEB4 during the first two weeks is
concurrent with the process of synaptogenesis, which prompts the likelihood that CPEBs
are either of key significance to the process of synaptogenesis, or their expression is
regulated as a consequence of synapse formation.
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Eye opening may dampen the

enhanced expression of CPEBs. Future investigations on the interaction of CPEB
proteins and synaptic mRNAs may be devoted to synaptic molecules such as GluR2
mRNA, a known target of CPEB3.
AMPAR is known for its key role in fast synaptic transmission. The expression of GluR
2/3 and 4 before the emergence of synaptic transmission indicated a role of AMPAR in
the establishment of retinal circuitry (Grunder et al. 2000a; Chang and Chiao 2008). The
onset and regulation of GluR2 expression in the retina is in accordance with the process
of synaptogenesis: starts early in the postnatal period, and reaches a peak before eyeopening (Johansson et al. 2000; Grunder et al. 2000a). In the inner plexiform layer, the
pattern of GluR2 expression changes from a disoriented pattern at birth to a laminated
pattern prior to eye-opening (Johansson et al. 2000), a manifestion of a reorganization of
synaptic circuits.
Synaptogenesis in early development is activity-dependent (Wong and Ghosh 2002).
The formation of synaptic contacts requires the mobility of dendritic structures regulated
by spontaneous glutaminergic transmission. The rate of dendritic mobility was
decreased by antagonists of both NMDA receptors and non-NMDA glutamate receptors
(Wong et al. 2000). In the long term plasticity in the hippocampus and the visual cortex,
NMDAR activation results in CaMKlla-mediated delivery of AMPAR to the synaptic
membrane for enhanced synaptic efficacy, and CPEB1 mediates rapid local translation
of CaMKlla mRNA in active synaptic sites. In the hippocampus, under a different
stimulus - kainate induced seizure, CPEB3 regulates the translation of GluR2 mRNA
(Huang et al. 2006). If similar machinery is harnessed for synaptogenesis, then one may
relate such key molecules to CPEB. The expression pattern for CPEB3 presented here
is similar to the pattern for retinal GluR2 (Dijk and Kamphuis 2004; Grunder et al. 2000a;
Hack et al. 2001; Hamassaki-Britto et al. 1993; Kamphuis et al. 2003). Both are
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expressed in the same type of cells, and both are up-regulated in the first two weeks.
Since CPEB3 protein becomes phosphorylated at Serine 197 in activated synaptosomes
(Munton et al. 2007), a determination of the phosphorylation status of CPEB3 at each
age would be useful to further establish the relationship of GluR2 and CPEB3.
Manipulation of CPEB3 expression in vivo, including the use of knockout mice, could be
used to advance the exploration of the role of CPEB3 in the retina. MAPK, BDNF/trkB,
and certain cytoskeletal proteins are involved in synatogenesis as well (Job and
Lagnado 1998; Schmitz et al. 1993; Oliveira et al. 2008; Cohen-Cory and Lom 2004; Liu
et al. 2007a).

MAPK and BDNF both demonstrated elongated poly(A) tails during early

development. Further experiments are needed to establish the relationship of their
polyadenylation with particular CPEBs.
In addition to GluR2, several other synaptic molecules have been reported as being
developmentally up-regulated in the retina, such as AMPAR subunits GluR1, GluR4,
NMDAR subunits NR1, NR2A, NR2B, and CaMKlIa (Grunder et al. 2000a; Chang and
Chiao 2008; Xue and Cooper 2001; Xue et al. 2001). These molecules are expressed in
a similar spatial pattern as CPEBs: in ganglion cells and amacrine cells. Additionally,
our results on potential CPEB1 target mRNAs revealed that four out of eight genes were
up-regulated during development: CaMKlIa (which confirms the previous finding by
Xue), Ppp2r2b, RBP-3, and Ttr. The patterns of these genes in early development were
similar to that of CPEB1, 3 and 4. It is yet to be determined whether any of the
aforementioned mRNAs are suitable targets of CPEB3. Bioinformatics analysis
screening for the U-rich hairpin loop structure in the 3' UTR of mRNAs, the binding site
of CPEB3 protein (Huang et al. 2006) could be used to predict the suitability of the
interaction between CPEB3 and particular mRNAs. In vivo binding assays could then be
employed to further validate such mRNA-protein interactions (Huang et al. 2006).

177

5. CPEB1, CPEB3, CPEB4 and synaptic maturation
Although most morphological and neurochemical properties of the retina (i.e., the
numbers of conventional and ribbon synapses, the expression of receptors for
neurotransmitters) have reached the adult level at the time of eye opening (Fisher 1979a;
Sassoe-Pognetto and Wassle 1997), the maturation of synaptic function continues for
several weeks after eye-opening. For example, the synaptic strength of the RGCs,
measured as the frequency of spontaneous synaptic activity, was low around the time of
eye opening, and surges around P25 both in spontaneous excitatory postsynaptic
currents (sEPSCs) mediated by glutamate receptors and in spontaneous inhibitory
postsynaptic currents (sIPSCs) mediated by GABAIglycine receptors (Tian and
Copenhagen 2001). The establishment of ON versus OFF pathways and the dendritic
pruning of the IPL occur to a large extent after eye opening.
The dendrites of RGCs ramify throughout the INL at the early postnatal time (Oiao et al.
2004). Over development most of those dendrites achieve stratified patterns either in
sublamina a or sublamina b of the INL. A significant portion of this morphological
change occurs after eye opening. The ratio of bi-stratified RGCs (respond to both ON
and OFF stimulus) to monostratified RGCs (respond to either ON or OFF stimulus)
declined significantly in two to three weeks after eye opening (Tian and Copenhagen
2003).
The dendritical pruning in the inner plexiform layer is concurrent with the maturational
alteration of bistratified ON-OFF responsive bipolar cells to monostratified ON or OFF
responsive cells. It is postulated that the RGCs achieve their assignment to ON or OFF
pathways by pruning their dendrites - removing "misplaced" dendrites and limiting their
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dendrites only in sublamina a or sublamina b. Both the alteration of ON and OFF
pathways in AGCs and the dendritic pruning in the IPL are activity dependent. The agedependent decline of bistratified AGCs was completely blocked in dark-reared animals.
Light deprivation also retarded the maturational loss of ON-OFF responsive AGCs (Tian
and Copenhagen 2003). Similar retardation in the synaptic pruning of bistratified AGCs
was also observed in pharmacological studies which mimic the effect of light deprivation.
Injection of 2-amino-4-phosphonobutyrate (APB), a compound that specifically blocks
the release of glutamate by cone-driven ON bipolar cells and rod driven bipolar cells,
diminished the maturational stratification process of AGC dendrites (Bisti et al. 1998;
Bodnarenko and Chalupa 1993; Bodnarenko et al. 1995). Such delays in alteration of
ON and OFF pathways and dendritic refinement elicited by light deprivation were
reversible both in young and adult animals, however, the time course of such recovery is
age-dependent, with younger animals requiring longer time for recovery (Tian and
Copenhagen 2001).
The mechanism underlying the activity-dependent maturation of ON and OFF pathways
is yet to be fully delineated. One attractive hypothesis is that the retrainment or removal
of a dendrite is regulated by NMDA receptors. Activity strengthens synaptic contacts
that fire synchronously and eliminates the ones firing asynchronously. The
developmental shift of predominant NA1/NA2B receptors to more NA1/NA2A receptors
may be a key player in this mechanism. The downstream cascade of NMDAA activation
is yet to be clarified for this process. One possible direction is to investigate whether
CPEBs playa role following NMDAA activation. The expression of NA2A subunit is agedependent and is decreased in dark-reared developing retina (Xue and Cooper 2001).
Our study demonstrated that CPEB1, CPEB3 and CPEB4 have a similar age-dependent
up-regulation in the retina. Whether the up-regulation/activation of CPEBs is dependent
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on NMDAR activity could be determined in the future with the aid of the visual
deprivation model. Agonists or antagonists of the glutamate receptors can also be
applied in vivo. Synaptic enrichments of potential targets of CPEBs, such as CaMKIl for
CPEB1 and GluR2 for CPEB3, can also be studied in this scenario. The causal
relationship is still in question: Is CPEB up-regulation driven by the process of synaptic
maturation or vice versa?

6. Synaptic plasticity in the adult retina
Both our real-time PCR data and Western blot data indicated that CPEB1 and CPEB3,
and CPEB4 continue to increase after synaptogenesis and synaptic maturation, and
reaches a plateau in adulthood (P60). This suggested CPEBs are functional in the adult
retina. This may be related to certain forms of synaptic plasticity in the adult life.
Neuronal plasticity has been historically characterized as a feature of the developing
central nervous system, but there is an increasing amount of evidence which indicates
that activity-dependent synaptic plasticity can occur both during development and
adulthood. One form of activity dependent plasticity in the adult retina is regulated in the
course of normal diurnallightldark cycle. GluR2-containing AM PAR undergoes rapid
cycling in the retinal ganglion cells and amacrine cells via endocytosis and exocytosis
(Xia et al. 2006). Synaptic quiescence in darkness drives rapid cycling which leads to
AMPARs altering from GluR2-containing to GluR2-lacking on synaptic membrane. On
the contrary, synaptic activity in the light inhibits cycling and stabilizes AMPAR as
predominantly GluR2-containing on the surface. The activation of AM PARs is critical for
the switching between cycling and non-cycling states (Xia et al. 2007). The relationship
between AMPAR cycling and synaptic function is not well understood, but is believed to
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have a role in certain forms of synaptic plasticity. Such cycling of AMPAR is present in
hippocampus neurons as well, and is regulated by NMDAR activation and calcium influx
(Biou et al. 2008). The cycling of GluR2-containing AMPARs plays a critical role in
synaptic plasticity in the adult hippocampus (Luscher et al. 1999).
The expression of BDNF in the retina undergoes diurnal cycles under normal light/dark
conditions. The level of BDNF is higher during the light than during the dark (Pollock et
al. 2001, Cooper et al. 2008). BDNFlTrkB pathway has been proposed as a mediator in
activity-dependent plasticity. BDNF can be retrogradely transported and act as a
regulator of the bi-directional synaptic communication (An et al. 2008; Bramham and
Messaoudi 2005; Carvalho et al. 2008; Cohen-Cory and Lorn 2004; Tongiorgi et al. 1996;
Tongiorgi et al. 2006). Under diurnal conditions BDNF may modulate the efficacy and
stability of synaptic connections in visual circuits. Since BDNF has CPE and PAS motifs
in its 3' UTR, the role of CPEBs in the regulation of BDNF during the light/dark cycles
can be further explored using the diurnal model.
Increasing evidence demonstrates that the outer plexiform layer of adult retina also
possesses some degree of synaptic plasticity. For example, ectopic dendrites grow to
make new connections in the outer plexiform layer in diseased or ageing retina (Eliasieh
et al. 2007; Sullivan et al. 2007). Such newly formed synapses are functional and
capable of releasing neurotransmitters. Whether CPEB3, which demonstrated strong
labeling in the OPL of the adult retina, is involved in such remodeling is a topic worth
pursuing in the future.

It is conceivable that some "consensus" molecules may be involved in synaptic plasticity
in both development and adulthood. Whether synaptic molecules such as GluR2 and
CaMKlla work together with CPEBs in synaptic plasticity in the adult retina is a question
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also worth pursuing. It is likely that different members of the CPEB family, or even
different isoforms of the same paralog, are involved in distinct forms of synaptic plasticity
or in different stages of development.

7. Multiple CPEB3 isoforms in the retina suggest a level of complexity for CPEB3
activity

1) Multiple CPEB3 protein isoforms are present in the retina.
A previous study from Kandel's group identified two alternative splicing regions of
CPEB3 (Theis et al. 2003), which accordingly give rise to four different isoforms of
protein (isoform 1-4 in figure 29). In the current study, we identified a total of eight
variants of CPEB3 transcripts and seven isoforms of CPEB3 protein in the database
(figure 28, 29). Additionally, we reported for the first time a novel isoform of CPEB3
(figure 30c, "exon 11 missing").
Data derived from CPEB3 Western blots in the current study demonstrated a band as
-75kD (figure 35c) in the retina. This band may represent one or more of CPEB3
isoform 1-4, of which the predicted size is 78kD, 77kD, 75.5kD and 74.5kD, respectively
(figure 29). The composition of the -75kD band could be further analyzed in future
studies with techniques such as mass spectrometry (MS).

Results from CPEB3 Western blots demonstrated that besides the -75kD band, there
were two prominent bands around 130kD, one of which was absent when the antibody
was pre-absorbed with CPEB3-recombinant protein. Of interest, the intensity of this
band decreased during development of the retina. The -130kD band may be a dimer, a
pre-protein, or a prion form.

Each theory would explain the decrease in the relative
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amount of the -130kD band and the corresponding increase of the 75kD band.
However, this band was not weakened under reducing and denaturing conditions
(adding OTT or j3-ME and the samples boiled, data not shown), where S-S disulphate
bands, if any, should be opened up. Therefore, it seems unlikely for this band to be a
dimer of CPEB3. The speculation that it is a pre-CPEB3 needs further evidence.

It

could be investigated with the aid of Northern blots to determine whether a larger mRNA
corresponding to this protein is present. It can also be addressed with the aid of
immunoprecipitation and MS if sufficient amount of protein can be obtained. Another
speculation is that -130kD is a prion form of CPEB3.
characteristics with its Ap/ysia homolog (ApCPEB):

Mouse CPEB3 shares unique

a poly-glutamine track at the N-

terminus (figure 27). This short motif confers on several proteins, including the ApCPEB,
the structure flexibility to form prion (Darnell 2003; Si et al. 2003b; Olson 2005). Further
stUdy with the aid of mutations or chimera proteins could be used to address whether the
-130kD band is the prion form of CPEB3 in the mouse retina.

Two bands smaller than 75kD (figure 35c, 67kD and 62kD, respectively) in our Western
blots also disappeared when the antibody was pre-absorbed with the recombinant
CPEB3. These two bands could be possible cleavage products from the -75kD band or
the 130kD band. It is also possible that they are two different isoforms of CPEB3, since
their sizes are consistent with that of isoform 7 and isoform 5, respectively (figure 29).
Likewise their identities can be determined with mass spectrometry if sufficient material
can be isolated from the retina.

Quantification of Western blots on CPEB3 demonstrated that the level of CPEB3 protein
(the 75kD band) was significant up-regulated from age P1 and P7 to P12.

This is

consistent with the change of CPEB3 mRNA levels during development. It is also in
accordance with in situ hybridization results at different ages (data not shown).
183

Synaptogenesis in the mouse retina occurs prominently before eye-opening.

This

prompted a likely correlation between the function of CPEB3 and synaptogenesis in the
retina. It would be very interesting to look into the substrate mRNAs that are regulated
by CPEB3 with regard to whether they are components for the construction of synapses.
One of the factors now known to be regulated by CPEB3 in is GluR2 (Huang et al. 2006),
which is implicated in basic synaptic transmission in the hippocampus (Meng et al. 2003).

2) CPEB3 variants provide for a higher level of regulation complexity than has been
hitherto recognized.
The large number of variants in the coding region, together with variability in the 5' UTR,
and 3' UTRs of CPEB3 provides evidence for an unexpected level of complexity in
regulatory and functional properties of CPEB3. First of all, the differences in its protein
sequences (resulting from alternative splicing in coding exons) may involve the
attachment of discrete "tags" to protein isoforms so that they may function in different
temporal and spatial patterns, possibly on different RNA targets, with different protein
partners, or upon different stimuli. Activation, inhibition or even turnover could also be
affected by the affinity for different kinases, phosphatases, endopeptidases. Secondly,
the regulatory and functional properties can result from the differences in the 5' UTR and
3' UTR regions of the CPEB3 mRNAs. The UTRs may harbor signal motifs for localizing
mRNAs to different sub-cellular compartments, subjecting the mRNA to distinct
translation mechanisms, or degrading the mRNA via discrete pathways. One striking
phenomenon is the presence of CPE motifs in the 3' UTR of CPEB3 mRNA, which casts
CPEB3 mRNA as a good candidate target for CPEB1 protein.
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8.

Comparison of CPEB1 and CPEB3:

1) CPEB1 and CPEB3 have different distribution patterns in the retina
Our study in the retina revealed different patterns of CPEB1 and CPEB3. First, in the
RGC layers, CPEB3 is strongly expressed in the majority of the cell soma; while CPEB 1
in expressed in a few cell soma. Secondly, both are strongly expressed in the INL. But
CPEB1 demonstrated laminar structures. At least two layers are distinguishable in the
IPL. In comparison, the pattern of CPEB3 in the IPL is more diffuse. Last, labeling in
the OPL was strong for CPEB3, but barely detectable for CPEB1.

2) CPEB1 and CPEB3 may play different roles in the retina
The comparision between the expression patterns of CPEB1 and CPEB3 suggested that
CPEB1 and CPEB3 may have different roles in the retina. Different distribution for
CPEB1 and CPEB3 has been shown in the hippocampus, where CPEB3, but not
CPEB1 was responsive to kainate acid induced seizure (Theis et al. 2003). Protein-RNA
binding assays revealed that CPEB1 and CPEB3 recognize different subset of mRNA
targets (Huang et al. 2006). Although postnatal development seemed to regulate the
expression of both, CPEB1 and CPEB3 may respond to different types of stimuli in the
retina. Other experimental paradigms such as light! dark cycles, dark-rearing, or injury/
aging models may be used to further differentiate the two.
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3) There may exist a feedback loop between CPEB1 and CPEB3
One intriguing property of CPEB3 is that its mRNA contains two CPE motifs in the 3'
UTR. This casts CPEB3 as a good candidate for CPEB1-regulated translational control.
Should this be indeed the case, CPEB3 may provide a feedback loop for CPEB1
activation. It could be a positive feedback which augments and expedites the effect of
CPEB1 activation; or a negative feedback that eases the effect of CPEB1 activation.

In summary, our data described the expression patterns of four CPEBs in the retina.
There were some similarities and discrepancies between the four, both spatially and
temporally. The function of each CPEB in the retina is yet to be delineated. It is possible
that some degree of functional compensation of redundancy exists between certain
CPEBs. Based on the prevalent studies on CPEB1, which have been devoted to the
region of hippocampus in the CNS, we speculate that CPEB1 and the other CPEB
paralogs are involved in synaptic activity, possibly synaptogenesis and certain forms of
synaptic plasticity in the retina. A variety of congenital or acquired conditions are the
leading causes of retinal degeneration that leads to blindness. Current knowledge about
the capacity for remodeling and restoration of the retina is of key significance for
developing cures for degenerative retinal diseases. The exploration of the roles of
CPEBs and their relative abilities to regulate protein translation in the retina will advance
our understanding on the structure and function of the retina, especially pertaining to
neural plasticity.
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CHAPTER VI
FUTURE DIRECTIONS

Although some functional studies have been pursued for CPEB1, and to a less extent,
for CPEB3, in the hippocampus and visual cortex, little is known with regard to the
function of each CPEB in the retina. Some aspects of the function may be investigated
with recapitulation of available techniques used in the other systems, in some current
established in vitro or in vivo models.

1. In vitro studies: Identification of mRNA targets for each CPEB.
One of the important aspects regarding the functions of CPEB 1-4 is the substrate
specificity of each: the mRNA targets they recognize and mediate. Our study identified
some potential mRNA targets for CPEB1. Additionally, potential targets of CPEB2-4
may be identified more extensively using the following approach 1). The interaction
between the mRNA targets and individual CPEB proteins can be further validated using
the following experiments 2) and 3).
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1) SELEX screening in combination with bioinformatic tools
Huang and colleagues used SELEX (systematic evolution of ligands by exponential
enrichment) method to determine that the recognition of CPEB3 of its target mRNAs
requires a secondary structure in the 3' UTR of the mRNA (Huang et al. 2006). A pool
of random 2S-mer RNAs was generated from an oligonucleotide library composed of
random 2S-mers flanked by constant regions for PCR. The RBD (RNA binding domain)
of CPEB3 or CPEB4 were mixed with the mixed RNA pool. However, in the experiment
followed, they found that the 3' flanking sequence is critical for the formation of the
secondary structure during the recognition of CPEB3. Since the 3' flanking sequence
used in their experiment was a constant sequence which was arbitrary by nature, the
sequence of the recognition motif derived from their experiment may be limited.
A modified version of this experiment can be performed with the following modification:
Generate a pool of random SO-mer RNAs from an oligonucleotide library composed of
random SO-mers flanked by constant regions for PCR. Use the pool of 50-mer RNA in
the binding assays. ("SO" is derived from: the length of the previous 2S-mer plus the
length of the 3' flanking sequence). Follow the same procedures for the rest of the
experiment.
This modification of the SELEX experiment is more inclusive and is likely to generate
more variants of the recognition motif for the CPEB tested. Then extend from "CPE
Detector" program, these variants can be screened in 3' UTR databases, and potential
mRNA targets can be extracted computationally from the database. Promising mRNA
candidates can be validated experimentally using the following in vitro binding assays or
in cell knockdown/over-expression analysis.
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2)

In vitro binding assays

Partial mRNAs of interest (with the 3' UTR) can be in vitro transcribed from PCR
products using T7 promoters and radioactively labeled. Protein of interest (CPEB 1-4)
can be expressed as recombinant protein and then refolded to natural conformation if
necessary, or purified from tissue as biologically active form using immunoprecipitation.
The enriched RNA probes can then be incubated with specific protein. The RNA:protein
complex can then be subjected to gel shift assay using PAGE gel. The presence or
absence of binding can be verified by the shift or no-shift of the band from the free probe
band. Synthesized mRNA fragments without binding sites for CPEBs can be used as a
negative control to account for non-specific binding.
The in vitro binding assay can also be used in large scale screening from a biological
sample. For example, total mRNA from the retina can be applied in incubation with
CPEB proteins. The binding complex will then be washed, and the mRNA targets eluted
and extracted. The identity of the mRNAs can be identified using microarray.

3) In cell knockdown/over-expression analysis
Cell knockdown or over-expression assay is another alternative to identify mRNAs
associated with the CPEB. CPEB1 acts as a translational suppressor when inactivated,
and an activator when activated, and the binding of CPEB1 to the mRNA is constitutive.
This is also true for CPEB3 with respect to its interaction with GluR2. Therefore, a
change in the translational levels of the target mRNAs should be detectable regardless
of the stimulus (down-regulation without stimulus, up-regulation with appropriate
stimulus).
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For potential candidates, for example, from SELEX screening in combination with
bioinformatic tools, candidate proteins can be validated using quantitative assays such
as Western blot. Expected alterations in the level of proteins would be a strong indicator
of the association of the mRNA with CPEB. However, verification of the physical binding
of the two is still desirable.
The total protein extraction from CPEB knockdown/over-expression samples can also be
used in high-throughput analysis such as proteomics. The identity of down-regulated
proteins (in the absence of stimulus) or up-regulated proteins (in the presence of an
appropriate stimulus) can be verified with the protein extraction from na"lve cells as a
control.

2. In vivo studies
In vivo studies should be the eventual goal to delineate the role of CPEB in the retina.
Since it is highly likely that different CPEBs recognize discrete mRNA substrates and
may be responsive to distinct stimuli, it is critical that appropriate models are used.
Some experimental paradigms can be tested as discussed below:

1) Diurnal cycle model
As described in previous literature, GluR2-containing AMPAR undergoes rapid cycling in
ON ganglion cells under normallightldark cycles (Xia et al. 2007; Xia et al. 2006). The
rapid cycling of AMPARs is believed to maintain synaptic transmission and may be
related to several forms of synaptic plasticity. Light adaptation stabilizes it in a nontrafficking state, while dark adaptation switches it into a state of rapid cycling. The
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activation of AMPAR is critical for the switch (Xia et al. 2006), however the underlying
mechanism is yet to be discovered.
GluR2 is believed to be a target of CPEB3 in the hippocampus (Huang et al 2006).
However, whether CPEB3 mediates the translation of GluR2, or indirectly leads to the
activation of AMPAR in the retina, is a question yet to be addressed. The diurnal model
may serve as one diagram to explore this issue. siRNA of CPEB3 can be delivered to
retinal ganglion cells via intravitreal injection. The expression of GluR2 or the cycling
pattern of GluR2-containing AMPAR can then be determined.

2) Developmental model
The inner retina undergoes profound maturational remodeling during post-natal
development. Such process has been proven to be activity-dependent. Our study
demonstrated that CPEB1, 3 and 4 were up-regulated during development. CPEB1 and
CPEB3 demonstrated a different spatial pattern. It is not known whether the expression
of one or more CPEBs is activity dependent. Dark-rearing can be used during
development to investigate this question. Both the spatial localization of the CPEBs and
the quantitative level of CPEBs should be observed in dark-reared animals and in
normal-reared control.

3) Knockout mouse model
CPEB 1 knockout mice may be used in comparison to normal littermates for the
polyadenylation and translation of target mRNAs. Similarly, CPEB3 knockout mice can
be generated; the translation of known or potential mRNA targets of CPEB3 can be
191

evaluated. Immunohistochemistry can be used to determine affected areas/cell types of
the retina. Electrophysiology properties such as ERG, OPs, and EPSPs can be
measured to infer the effects of CPEB knockout on the functioning of the retina.
Behavior studies can be designed, if plausible, to elaluate the overall performance of
vision.

4) Photoreceptor degeneration models
The outer plexiform layer of the retina manifested a certain degree of plasticity in mutant,
diseases or aging that cause photoreceptor degeneration. Following the loss of synaptic
contacts in the outer plexiform layer, horizontal cells and bipolar cells in the inner nuclear
cells outgrow dendrites to the outer nuclear layer to form new connections with
photoreceptors. CPEB3 appeared to be present at the outer plexiform layer in the adult
mice (P60). The localization of CPEB3 with respect to pre-synaptic or post-synaptic
compartment needs to be further addressed. The expression pattern of CPEB3 can be
explored in the above models, which may provide some insights for its function in the
outer plexiform layer.

5) Application of kinase inhibitors, neurotransmitter agonists or antagonists

Four CPEBs may be responsive to different stimuli. For example, CPEB3 and CPEB4,
but not CPEB1, were up-regulated in kainate induced seizure in the hippocampus
(Huang et al. 2006). With the appropriate stimulus, the cascade of the activation of each
CPEB can be further delineated. CPEB1 is known to be activated by aurora kinase or
CaMKII, both of which require the activation of NMDA receptors. Sequence analysis
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indicated that CPEB2-4 do not possess phosphorylation site for aurora kinase, but
appear to be substrates for PKA, CaMKIl and p70S6 kinase. Inhibitors of these kinases
can be used to verify the cascade of phosphorylation under appropriate stimulus.
Agonists or antagonists of different types of neurotransmitter receptors can also be
applied to infer the requirement for the activation of receptors for each CPEB.
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APPENDIX: LIST OF ABBREVIATIONS

ABP

AMPA receptor binding protein

APB

2-amino-4-phosphonobutyrate

ApCPEB

Ap/ysia CPEB

AMD

age-related macular degeneration

AMPA

a-amino-3-hydroxy-5-methyl-4-isoxazole propionate

AMPAR

a-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor

AP

anterior-posterior

ARVO
B-PER

Bacterial Protein Extraction Buffer

CA1

Cornu Ammonis area 1

CA3

Cornu Ammonis area 3

ChAT

choline acetyl transferase

BDNF

Brain-derived neurotrophic factor

CaMK

Ca2 +/calmodulin-dependent protein kinases

CaMKIl

multifunctional Ca 2+/calmodulin-dependent protein kinases

CaMKlla

multifunctional Ca 2+/calmodulin-dependent protein kinases, a chain

CaMKllaB

multifunctional Ca2+/calmodulin-dependent protein kinases, a chain
isoformB

CPE

cytoplasmic polyadenylation element

CPEB

cytoplasmic polyadenylation element binding protein

CNS

central nervous system
213

CPSF

Polyadenylation Specific Factor

DV

dorsal-ventral

ERG

electroretinogram

elF4E

eukaryotic translational initiation factor 4E

elF4G

eukaryotic translational initiation factor 4G

EGR1

early growth response factor-1

ELK2

a potassium channel

ERK

extracellular signal-regulated kinase

EPSP

excitatory post synaptic potential

FAM

6-carboxyfluorescein

FMRP

Fragile-X Mental Retardation Proteins

GABA

gamma-aminobutyric acid

GEF

guanine exchange factor

GluR1-4

AMPA medated glutamate receptor subunit 1-4

GluR5-7

kainate receptor subunit 1-3

GRIA1-4

Glutamate receptor, ionotropic, AMPA mediated, subunit 1-4

GRIN1-3

Glutamate receptor, ionotropic, NMDA mediated, subunit 1-3

GRIK1-5

Glutamate receptor, ionotropic, kainate mediated, subunit 1-5

GST

glutathionine S-transferase

IACUC

Institutional Animal Care and Use Committee

iGluR

ionotropic glutamate receptors

INL

inner nuclear layer

IPL

inner plexiform layer

IPTG

isopropyl

IRBP

interstitial retinol binding protein

KA1-2

kainate receptor subunit 4-5

~-D-1-thiogalactopyranoside
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KAR

kainate receptor

LM-PAT

ligation-mediated polyadenylation test

LTD

long-term depression

LTP

long-term potentiation

MAP1a

microtubule-associated protein 1a

MAP2

microtubule-associated protein 2

MAPK

mitogen-activated protein kinase

MAPKK

MAP kinase kinase

MAP KKK

MAP kinase kinase kinase

MEK

MAP/ERK kinase

MF

mossy fiber (of hippocampus)

mGluR

metabotropic glutamate receptor

mGluR1-5

metabotropic glutamate receptor subunit 1-5

NMDA

N-methyl-D-aspartate

NMDAR

N-methyl-D-aspartate receptor

~NR1-3

NMDA receptor subunit 1-3

NR2A,2B

NMDA receptor subunit 2, isoformA, B

ONL

outer nuclear layer

OP

oscillatory potentials

OPL

outer plexiform layer

PABP

poly(A) binding protein

PAGE

polyacrylamide gel electrophoresis

PAP

poly(A) polymerase

PAS

polyadenylation signal

PAT

polyadenylation test

PCR

polymerase chain reaction
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PICK1

Protein Interacting with C-Kinase 1

PKA

protein kinase A

PKC

protein kinase C

Ppp2r1a

protein phosphatase 2, regulatory domain 1a

Ppp2r2b

protein phosphatase 2, regulatory domain 2b

proBDNF

the unprocessed pro-form of BDNF

PSD

post synaptic density

PVDF

Polyvinylidene Fluoride

RACE

rapid amplification of cDNA ends

RBD

RNA binding domain

RCM3

rat ,Qalmodulin

rdta

rod-ablated model

RGC

retinal ganglion cell layer

RACE

rapid amplification of cDNA ends

RPE

retinal pigment epithelium

RT

reverse transcription

RRF

RNA recognition motif

SDS

sodium dodecyl sulfate

SELEX

systermatic evolution of ligands by exponential enrichment

siRNA

small interference RNA

synGAP

synaptic Ras-GTPase activating protein

t-PA

tissue-type plasminogen activator

ITR

transthyreti n

UTR

untranslated region
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